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 Some Kinesiology Tape manufacturers claim that Kinesiology Tape (KT) can 
enhance performance and increase blood flow. Therefore, this study recruited 14 
healthy male subjects (college population, 182.9 ± 5.1 cm, 76.52 ± 10.2 kg). to 
complete an eight-day KT intervention experiment. On Day 1 and Day 2 the subjects 
did not wear KT. During Days 3 to 6 the subjects wore the KT on their dominant leg 
(treatment leg) only. Limb dominance was defined by asking the subjects which leg 
they use to kick a ball. During Days 7 and 8 the subjects did not wear KT. 
Furthermore, the KT was not worn on the non-dominant leg (control leg) during the 
study. During testing each subject performed a fatiguing isotonic flexion/extension 
exercise with a single leg on a Biodex, and switched to the other leg after the first leg 
exercise was complete. Fatigue was defined by when a subject could no longer 
perform the exercise. 
 The time to fatigue (TTF), number of cycles, and rate (number of cycles over 
TTF) were recorded as performance measures. Muscle oxygenation data including 
sitting baseline, minimum rSO2 levels, and time to minimum rSO2 levels in the trial 
were assessed to determine the influences of KT on blood flow. The confidence level 
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in this research was set at 95%. The time series was analyzed to check the root 
cause of any performance enhancement. 
 The results suggest that KT did not enhance the performance since the TTF 
and rate increased most of the days in both the taped and control legs. Furthermore, 
the time series analyses support the finding that the TTF and rate performance was 
enhanced by a learning effect. The muscle oxygenation results suggest the Vastus 
Medialis (VM) minimum rSO2 were increased by the KT. Even though the Vastus 
Lateralis (VL) sitting baseline show a statistically significant increase (p=0.045), the 
Power analysis suggest that the results need more subjects to avoid type I error. In 
conclusion, the KT type and brand utilized in this research did not support the 
manufacturers claim regarding enhanced performance. However, the muscle 
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Chapter 1: Introduction 
1.1 Background  
Muscle soreness and muscle pain are common side effects after exercising and 
strenuous work activity. Usually people take pills or use ointments to reduce the 
pain, which might have some side effect or require dietary restrictions, etc. As an 
alternative, in the 1970s, Dr. Kenzo Kase developed Kinesiology Tape (KT) which 
advertises that it can help rehabilitate individuals suffering from muscle pain and 
soreness. Not only do KT manufacturer’s claim to balance the muscles strength 
during exercise, but also delay fatigue, improve endurance and oxygenation of the 
muscle, and reduce pain and the likelihood of injury.  
 In previous studies the KT has been applied to the leg or arm muscles (Gart, 
2016), which are the body parts that usually get sore after exercising. Different 
sports, people and injuries will have different demands. However, KT can also be 
used on other muscles such as the waist (Gak, 2011). The research also states that 
KT may be a supplementary treatment method for acute LBP, and could be used in 
the prevention and treatment of occupational LBP. Another study looked at the neck 
muscles (González-Iglesias, 2009) which claims that KT significantly improves the 
pain and cervical range of motion, but may not be clinically meaningful. 
 In 1980 Dr. Kase established the Kase Chiropractic Institute and the kinesio-
taping method that provided correct application guidance to the user. Correct 
application of the KT is supposed to enhance the efficiency of recovery (Kase, 2003). 
Dr. Kase, who invented the tape, explained that the fundamental concept of KT is 
that, after adhesion, it will stretch the skin to promote blood flow and improve 
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performance, which will function to both protect from injury and enhance 
rehabilitation following injury. 
 During the 1990s, after the KT patent expired, many competitor companies 
started introducing similar tapes. The tape manufacturer’s nowadays claim that the 
tape can not only improve recovery from muscle pain, but also can enhance user’s 
performance, reduce fatigue, improve blood flow to the muscles, and even prevent 
injury. Numerous athletes have begun using the tape to enhance performance as 
well.  For example, a famous basketball player in the NBA - James Harden - puts on 
the tape for every game. James Harden’s reasoning is that he believes that KT can 
prevent him from getting injured, and can also maximize his performance through 
increasing blood flow. 
1.2 Previous Research 
 A Google Scholar search revealed over 20,000 research articles related to KT 
were published since 1990. Due to the nature of KT claims, most of the research 
studies were targeting a specific muscle or a group of muscles to which the tape was 
applied. Further, different parameters of muscle performance (isometric, isokinetic, 
isotonic) were commonly used in the investigations 
 Isometric: An exercise where the subject exerts against a fixed object (velocity 
equals zero), with the position determined by the experiment designer, and exertions 
must be maintained for at least six seconds. Isometric exercises are used to 
determine the maximum muscle strength (Perrine, 1969). 
 Isokinetic: Eccentric/concentric contraction at a constant velocity defined by 
the experiment designer. The resistance varies throughout the range of motion and 
the test is used to determine maximum strength (Perrine, 1969). 
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 Isotonic: A dynamic motion flexion/extension exercise with constant 
resistance and variable velocity. The maximum strength occurs over a short portion 
of the range of motion determined by the properties of the limb lever system 
(Iellamo, 1997). 
 The acute effect of KT application has been widely researched at a number of 
joints, including the ankle (Simon, 2014; Fayton, 2013; Bicici, 2012; Shields, 2013; 
Briem, 2011; Wilson, 2015; Halseth, 2004), neck (González-Iglesias, 2009; 
Saavedra-Hernandez, 2012), legs (Wong, 2012; Fu, 2008; Huang, 2011; Słupik, 
2007), back (Gak, 2011), and shoulder (Kaya, 2010; Simsek, 2013; Hsu, 2009). 
However, only a few published studies have investigated longer-term KT application 
effects (H.J. Tsai, 2009; A. Ibrahim, 2015; A. Castro-Sánchez, 2012; D. Duracoglu, 
2005; S. Bicici, 2012; M. Gramatikova, 2016; M. Thelen, 2008).  
 Some previous studies have also been conducted with patients to investigate 
recovery efficiency (Ptak, 2013; Kaya, 2010; Luque-Suarez, 2014; Ibrahim; 
MacGregor, 2005; Castro-Sánchez, 2012; Duracoglu, 2005; Briem, 2011; Shields, 
2013; Jackson, 2016; Simon, 2014; González-Iglesias, 2009). Other studies have 
been conducted using healthy participants to investigate the effect on performance 
(Konishi, 2013; Poon, 2015; van Dieen, 2007; Gak, 2011; Tsai, 2009; Huang, 2011; 
Soylu, 2011; Słupik, 2007; Aktas, 2011; Lee, 2010).  
 A summary of some of the studies conducted using KT or otherwise having 
direct relevance to the current study is contained in Table 1. The studies included in 
this review were chosen based on the claims from Kinesiology Tape to enhance 
exercise performance and increase muscle oxygenation. Finally, other studies are 
included that investigated similar topics to the current study: leg exercises, case 
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control studies, the use of healthy subjects, or duration effects.  
 A study by Ruggiero et al. (2016) considered a 30 minute KT application to 
the lumbar spine of 24 low-back pain patients during isometric flexion-extension 
exercise. While the findings from this study indicate that after the KT was in place for 
a period of time that there was an enhancement of seated balance compared to a 
control, whether the results were caused by KT or by a learning effect is unknown 
because the experimental design did not consider daily data collection. In addition, 
the findings indicate that KT did not enhance the seated balance control in the short-
term since the improvement persisted after the KT was removed, suggesting that the 
root cause is related to learning effect.   
 KT has also been studied in the area of low back pain (LBP) since it is a very 
prevalent worldwide problem and affects 60% to 85% of the population during their 
lifetime (Burton, 1996). A three-day KT study found that the subjects who have LBP 
had improved muscle function and a progressive increase in trunk performance after 
KT application in addition to physical therapy (Gak, 2011). 
 A recent study investigated KT application for neck pain relief and posture 
correction. In the neck pain relief study (González-Iglesias, 2009), forty-one patients 
were chosen, and separated randomly into 2 groups. The experimental group had 
KT application with tension on the subjects’ cervical spine; the placebo group had 
the same KT application, but it was placed without tension. The cervical range-of-
motion was collected immediately after placement of the KT and 24 hours after 
taping. The results showed that the KT was more effective than the placebo.  
 In a postural correction study (Luque-Suarez, 2014) 130 participants were 
included and the two groups of KT application (with and without tension) were split 
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randomly. At 1 minute, 10 minutes, 60 minutes and 24 hours after taping the FPI 
score was collected to check on postural changes. The results demonstrated that 24 
hours of KT application was not found to be effective for patients with a pathological 
foot pronation. 
 Kaya (2010) conducted a study comparing KT application in addition to 
physical therapy modalities for patients with shoulder impingement syndrome. 
Significantly better arm and shoulder disability scores were achieved with the KT 
when compared to therapy alone. The authors also suggest that the KT could be 
used to cure shoulder impingement syndrome.  
 KT has also been used to aid in the recovery of proprioception among knee 
osteoarthritis patients. Sensorimotor training was compared to KT application and 
the training produced a better outcome (Ibrahim, 2015). The authors conclude that 
traditional sensorimotor training cannot be replaced by KT application therapy. 
 A study involving healthy subjects investigated the effect of KT placement on 
the lumbar portion of the spine and found significant improvements in subject 
maximal extension peak torque (Knapman, 2016). A competitor of KT claimed that it 
not only reduces patellofemoral pain (PFP), but also enhanced subjects’ isometric 
strength performance (MacGregor 2005). 
 Some previous studies collected data from healthy subjects to assess hand 
(Fu, 2008) and knee joint (Pliner, 2015) performance during isokinetic exercises after 
KT application. Both studies revealed that a short-term taping didn’t exhibit any 
significant improvements. The findings from another study by Wong (2012) showed 
no effect on isokinetic test knee torque generation with KT application using a 
Biodex. However, the time to peak extension torque in that study was significantly 
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reduced with KT application. The authors did not believe that KT application 
enhanced performance. However, the authors do not explain whether the finding 
was due to a “learning” effect or just a “placebo”.  
 In another study (Poon, 2014), 30 healthy subjects participated using 3 
different treatments: true facilitative KT, sham KT, and no KT. A knee isokinetic task 
was designed to investigate if the KT application on the quadriceps affects the 
normalized peak torque, normalized total torque, and time to peak torque at different 
speeds. The KT application was reported to either have a positive effect on the 
subjects or a “placebo” effect was present. 
 The possible benefits of KT were also tested for the rectus abdominis muscle 
during force-velocity parameters of trunk flexors using Biodex equipment (Plak, 
2013). A study group (32 people with tape) and a control group (20 people with no 
tape) were recruited, and each subject performed an isokinetic task with 5 
consecutive trunk flexion/extensions at a fixed angular velocity. The study group had 
KT applied after the first test. No significant difference was found between groups in 
this short-term isokinetic test.  
 Ibrahim et al. (2015) designed an 8 week long test to determine the influence 
of KT and sensorimotor training on the efficiency of osteoarthritis (OA) patients 
during knee isokinetic exercises, but the study did not record and test consistently 
over the entire period.  The result show that even though both techniques showed 
significant enhancement in performance, the sensorimotor training provided better 
improvement in exercise performance, which was collected by Biodex and a visual 
analogue scale, but the KT application produced greater pain reduction. However, it 
is possible that patients had recovered by themselves after 8 weeks. 
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 J.H. van Dieen (2009) used a Biodex, EMG, and NIRS to assess when the 
trunk extensor muscles fatigue during low-level activity, and how muscle activity and 
muscle oxygenation change in healthy subjects. The results show that NIRS and 
EMG are not correlated with each other. Although KT application is absent in this 
research, it nevertheless provides a good reference for discussing fatigue along with 
muscle oxygenation.  
 Maximal de-oxygenation of the muscles was examined in a study by Moalla 
(2006) without KT. 12 healthy children participated, and an isokinetic dynamometer 
recorded data during subject isometric exercise performance. NIRS and EMG were 
also used to record the muscle oxygenation and muscle activity. The results suggest 
that decrease in muscle oxygenation and blood volume is related to isometric 
exercise.  
1.3 Research Gaps and Study Motivation 
 Based on a review of the published KT research several gaps in knowledge 
can be identified. Although many KT research studies were designed to test with an 
exercise task, only a few of the studies were tested with isotonic exercise (Bicici, 
2012; Lee, 2011; Pliner, 2015; Cheng, 2005). Bicici (2012) used isotonic exercise on 
ankle sprains, and Lee (2011) tested the ankle but without KT, Cheng (2005) 
assessed leg muscle recovery of isotonic power, and the study from Pliner (2015) is 
the pilot for this research. Most of the published articles (Knapman 2016; Wong 
2012; Poon 2014; Vithoulk, 2010; Ptak 2013; Fu, 2012; Aktas, 2011; Lins, 2012) 
used isometric or isokinetic (Moalla, 2006; MacGregor, 2005; Kaya, 2010; 
Gramatikova, 2016; Briem, 2011; Fahs, 2015; Castro-Sánchez, 2012; Ruggiero, 
2015) exercise to examine muscle strength and torque produced. In this study, 
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isotonic exercise will be used to assess the performance of knee muscle fatiguing 
and fill the gap in knowledge.  
 Experiment duration is another gap. Although several studies used a long 
duration test (Table 1), very few have recorded the data every day.  Some studies 
have only conducted testing at the beginning and end of the experiment (Tsai, 2009; 
Ibrahim, 2015), while others have only recorded the data after a period of time 
(Castro-Sánchez, 2012; Duracoglu, 2005; Bicici, 2012; Gramatikova, 2016; Thelen, 
2008; Akbas, 2011). While a small number of papers collect the data throughout the 
experiment duration (Paoloni, 2011; Saavedra-Hernandez, 2012; Tsai, 2010; 
Simsek, 2013), none of the studies investigated fatigue or muscle oxygenation.   
 In particular, only two pilot studies discuss the muscle oxygenation in KT 
application (Pliner, 2015; Shah, 2017), which is an important topic to investigate due 
to the manufacturer claims that the muscle oxygenation will be changed by KT, and 
the increasing of muscle oxygenation can reduce the risk of injury. Regional oxygen 
saturation (rSO2) level is the variable that this study measured to present the muscle 
oxygenation result. In addition, only the pilot study in this research (Pliner, 2015) 
discusses the duration of flexion/extension exercise and its relationship with time to 
fatigue (TTF) and rate (frequency). 
 In this study, an eight-day isotonic knee flexion/extension fatigue experiment 
in which the data was collected every day was designed. The performance data 
collected were muscle regional oxygen saturation (rSO2) levels, time to fatigue 
(TTF), number of cycles and rate (calculated by number of cycles over TTF). None of 
the variables have been adequately explored in the past with regards to KT 
application.  The chosen task was knee flexion-extension since the study was a 
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case-control study design, and the dominant and non-dominant legs have been 
shown to have similar performance for the task (van der Harst, 2007). Other 
research also states that the two legs have close performance on different tasks (K. 
McCurdy, 2005; I. Sannicandro, 2014). 
1.4 Specific Aims and Hypotheses 
 Based on the research gaps identified above, the goals of this case-control 
research study are threefold:   
i. Assess the effectiveness of KT during an isotonic fatiguing knee 
flexion/extension exercise protocol by measuring the TTF and the number of 
cycles or rate. 
ii. Investigate the effect of KT application over an extended number of days. 
iii. Examine the residual effect after removal of the KT application. 
The specific aims are:  
1. Quantify the effect of acute KT application on TTF of the knee joint during a 
fatiguing isotonic knee flexion/extension exercise, investigate the effect of the 
duration of KT application on the TTF, and also examine the residual effect on 
TTF after KT is removed. 
Hypothesis 1: The acute KT application will delay the TTF in the treatment 
leg during the fatiguing isotonic knee flexion/extension exercise, the effect will 
become more prominent as the duration of tape application increases, and 
additionally have a residual effect to maintain or increase the TTF after KT is 
removed.  




Hypothesis 1b: The duration of KT application will have a positive effect 
on the TTF. 
Hypothesis 1c: The residual effect will maintain the delay of TTF after 
removal of KT. 
 
2. Quantify the effect of acute KT application on the rate of knee joint motion 
during a fatiguing isotonic knee flexion/extension exercise, investigate the 
effect of the duration of KT application on the rate, and also examine the 
residual effect on rate after KT is removed. 
Hypothesis 2: The acute KT application will increase the rate in the treatment 
leg during the fatiguing isotonic knee flexion/extension exercise, the effect will 
be more prominent with duration of tape application, and the improvements 
will be maintained or increased after removal of the KT. 
Hypothesis 2a: The acute KT application will increase the rate in the 
treatment leg. 
Hypothesis 2b: The rate will increase with continued KT application. 
Hypothesis 2c: The residual effect after KT application will exist and 
increase the rate in the treatment leg. 
 
3. Quantify the sitting baseline of rSO2 level increase due to acute KT 
application to the knee joint before the fatiguing isotonic knee 
flexion/extension exercise, investigate the effects of duration of KT application 
on sitting baseline rSO2 level changes, and additionally examine the residual 
effect on the sitting baseline rSO2 levels after KT removal. 
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Hypothesis 3: The acute KT application will increase the sitting baseline of 
muscle rSO2 levels in the treatment leg before the fatiguing isotonic knee 
flexion/extension exercise, the effect will be more prominent with duration of 
tape application, and additionally will also have a residual effect to maintain or 
increase the sitting baseline of muscle rSO2 levels after KT removal.  
Hypothesis 3a: The sitting baseline of rSO2 levels will increase after 
acute KT application. 
Hypothesis 3b: The sitting baseline of rSO2 levels will increase with 
duration of KT application. 
Hypothesis 3c: The sitting baseline of rSO2 levels will increase by the 
residual effect from KT application. 
 
4. Quantify the minimum of rSO2 level changes due to acute KT application to 
the knee joint during the fatiguing isotonic knee flexion/extension exercise, 
investigate the effects of duration of KT application on minimum rSO2 level 
changes, and additionally examine the residual effect on the minimum rSO2 
levels after KT removal. 
Hypothesis 4: Acute KT application will change the minimum of muscle rSO2 
levels in the treatment leg flexors/extensors during the fatiguing isotonic knee 
flexion/extension exercise, the effect will be more prominent with duration of 
tape application, and additionally there will be a residual effect to maintain or 
change the minimum rSO2 levels after KT removal.  




Hypothesis 4b: The minimum of rSO2 levels will change due to duration 
of KT application. 
Hypothesis 4c: The residual effect after KT application will exist and 
change the minimum rSO2 levels in the treatment leg. 
 
5. Quantify the time to minimum rSO2 level changes due to acute KT application 
to the knee joint during the fatiguing isotonic knee flexion/extension exercise, 
investigate the effects of duration of KT application on time to minimum rSO2 
level changes, and additionally examine the residual effect after KT removal 
on the time to minimum rSO2 levels. 
Hypothesis 5: The acute KT application will change the time to minimum of 
muscle rSO2 levels in the trial in the treatment leg flexors/extensors during the 
fatiguing isotonic knee flexion/extension exercise, the effect will be more 
prominent with duration of tape application, and additionally there will be a 
residual effect to maintain or change the time to minimum rSO2 levels after KT 
removal. 
Hypothesis 5a: The time to minimum of rSO2 levels in the trial will 
change after acute KT application. 
Hypothesis 5b: The time to minimum of rSO2 levels in the trial will 
change due to duration of KT application. 
Hypothesis 5c: The residual effect after KT application will exist and 








Table 1: Summary of the reviewed articles 
Article Information Article Topics 














































































1 Oscar M.H. Wong 2012 Physical Therapy in Sport V V V    V 
 
2 T.C Fu 2008 Journal of Science and Medicine in Sport  V V    
  
3 H.Y. Chang 2010 Physical Therapy in Sport V V     
  
4 Y. Konishi 2013 Journal of Science and Medicine in Sport V V V    V 
 
5 K.Y. Poon 2015 Manual Therapy V V V    V 
 
6 Y. Shah 2017 Journal of Bodywork and Movement Therapies V V     
 V 
7 H. Preece 2016 Journal of Bodywork & Movement Therapies V V     
  
8 W. Moalla 2006 Journal of Sports Sciences  V V    V V 
9 J. H. van Dieen 2007 Journal of Electromyography and Kinesiology  V     V V 
10 J. Pliner 2015 Conference Paper V V V V V  V V 
11 A. Ptak 2013 Journal of Back and Musculoskeletal Rehabilitation V      V  
12 H.B. Gak 2011 
International Journal of Occupational Medicine and 
Environmental Health 
V V  V     
13 E. Kaya 2010 Clinical Rheumatology V   V     
14 A. Luque-Suarez 2014 Physiotherapy V        
15 M. Gart 2016 Hand Clinics V V  V     
16 H.J. Tsai 2009 Support Care Cancer V V  V  V   
17 C.Y. Huang 2011 BioMedical Engineering OnLine V V V V     
18 A. Ibrahim 2015 
International Journal of Therapies and Rehabilitation 
Research 
V  V V  V V  







20 K. Kase 2003 
Clinical Therapeutic Applications of The 
KinesioTaping Method 
V  V      
21 K. MacGregor 2005 Journal of Orthopaedic Research V  V      
22 H.J. Knapman 2016 Physical Therapy in Sport V V  V   V  
23 M.H. Lee 2011 Journal of Physical Therapy Science V V       
24 A.R. Soylu 2011 Med Sport. V V       
25 I. Vithoulk 2010 Isokinetics and Exercise Science V V       
26 A. Słupik 2007 Orto Traum Rehab. V V       
27 A. Yoshida  2007 Res Sport Med. V V       
28 G. Aktas 2011 Isokinetics and Exercise Science V V  V     
29 J.H. Lee 2010 Journal of Physical Therapy Science V V       
30 J. González-Iglesias 2009 Journal of Orthopaedic & Sports Physical Therapy V   V     
31 J.T. Han 2014 Journal of Physical Therapy Science V V       
32 A.M. Castro-Sánchez 2012 Journal of Physiotherapy V   V  V   
33 C.A. Fahs 2014 Clinical Physiology and Nuclear Medicine  V V    V V 
34 M. Nakajima 2013 The International Journal of Sports Physical Therapy  V V       
35 S. Semple 2012 Journal of Physical Therapy Science V V     V  
36 D. Duracoglu 2005 Journal of Clinical Rheumatology   V V  V V  
37 S. Bicici 2012 The International Journal of Sports Physical Therapy V    V V   
38 M. Gramatikova 2016 Sport Science V  V V  V   
39 S. Zhang 2016 Journal of Science and Medicine in Sport V V  V   V  
40 K. Briem 2011 Journal of Orthopaedic & Sports Physical Therapy V        
41 C.A. Shields 2013 American Orthopaedic Foot & Ankle Society V        
42 K.Y. Lee 2011 
International Journal of Precision Engineering and 
Manufacturing 
 V   V    
43 D. DeLorey 2004 The Physiological Society  V V     V 
44 J. Simon 2014 Clinical Journal of Sport Medicine V   V   V  
45 S. Fayson 2013 Research in Sports Medicine V V       







47 S. Ruggiero 2017 Journal of Sports Sciences V V       
48 M. Thelen 2008 Journal of Orthopaedic & Sports Physical Therapy V   V  V   
49 T. Halseth 2004 Journal of Sports Science and Medicine V V       
50 C.A.A. Lins 2013 Manual Therapy V V  V   V  
51 G. Strutzenberger 2015 Europe Journal of Sports Science V V    V   
52 E. Akbas 2011 Acta Orthopaedica et Traumatologica Turcica V     V   
53 A. Cheng 2005 Journal of Applied Physiology  V V  V  V  
54 S. Álvarez-Álvarez 2014 Journal of Back and Musculoskeletal Rehabilitation V V       
55 G. Llopis 2012 Fisioterapia V     V   
56 M. Paoloni 2011 Europe Journal of Physiology Rehabilitation V     V   
57 A. Aystar 2011 Isokinetics and Exercise Science V      V  
58 M. Saavedra-Hernandez 2012 Journal of Orthopaedic & Sports Physical Therapy V     V   
59 C.T. Tsai 2010 Journal of Musculoskeletal Pain V   V  V   
60 H.H Simsek 2013 Acta Orthopaedica et Traumatologica Turcica  V     V V  




Chapter 2: Methods 
The University of Wisconsin-Milwaukee Institutional Review Board approved 
all the study materials and protocols in this research. (Protocol #15.372).  All 
experimental sessions were conducted at the University of Wisconsin-Milwaukee 
Spine Biomechanics Laboratory (USRB 289). 
2.1 Subjects 
 Fourteen healthy male college students volunteered to participate in this 
project and signed a consent form prior to testing. The subjects ranged in height and 
weight which averaged 182.9 ± 5.1 cm and 76.52 ± 10.2 kg respectively. Subjects 
were asked whether they had a leg injury in the past six months, or if they had ever 
sustained any other serious injury.  Individuals who had a recent leg injury or an 
injury that would prevent them from performing the knee flexion/extension protocol 
optimally were excluded from the test.  
The study protocol was explained to the subjects upon arrival and they were 
asked to conduct their normal daily activities during the entire testing duration (8 
days). The dominancy was determined by asking the subjects which leg they use to 
kick a ball. 
2.2 Experiment Design 
An eight-day case-control study was designed to examine the effect of KT on a knee 
joint isotonic flexion/extension fatigue protocol.  Commercially available “Kinesio-
Tape” brand KT was used in this study (Figure 1).  All data was collected bilaterally 
(left and right knee) following the same protocol over eight consecutive days. The 





Figure 1: Kinesio-Tape (KT)  
retrieved from: https://www.kttape.com/kt-tape-pro-kinesiology-tape  
 
During the experiment no KT was applied to the subject’s non-dominant leg 
(control leg). The dominant leg (treatment leg) was left untaped (nKT) for the first two 
days. The KT was applied on Day 3 and was kept on through Day 6. The KT was 
then removed. The final two testing sessions were conducted 24 hours after KT 
removal (Days 7 & 8).  Testing with no KT application on Day 1 was used as a 
“training” session and was not used for analysis. The data from Day 2 to Day 8 was 
used to establish individual performance differences with and without KT, as well as 
for the assessment of potential “learning” effect (K. Jackson et al., 2016; J.T. Han et 
al., 2014; C. Fahs et al., 2015).The test began at the same time every day (± 2 
hours), in order to eliminate any potential influence of time of day on performance. 
The start time was determined by the start of testing on the first day (H. Chtourou et 




Table 2: Experimental design schedule overview 
 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 
Treatment leg nKT KT nKT 
Control Leg nKT 
 
 On Day 3 of the protocol, KT was applied to the dominant knee per the 
manufacturer’s protocol (Kase, 2003). KT placement, and subsequent sensor 
placement, was conducted by the same researcher each day for all subjects to avoid 
any error due to differing techniques of multiple researchers. The following outcome 
parameters of interest were considered and are described in more detail in the 
subsequent sections: 
Rate = number of cycles (flexion/extension) per second 
Time to fatigue (TTF) = time to the point that the subject could no longer perform the 
task 













2.3 Equipment and Data Collection 
 2.3.1 Biodex 
 The knee flexion/extension exercise was recorded using a Biodex 
dynamometer System 4 (Biodex Medical Systems, NY).  
 
Figure 3: Subject’s initial position on Biodex 
 Subjects were strapped down on the positioning chair with two seatbelts. One 
belt was positioned across the chest, and another belt was tied on the tested leg as 
depicted in Figure 3. The isotonic test was administered for knee flexion and 
extension exercises with the resistant load set at 40 pounds and no velocity control. 
The initial position of the knee was set at 90-degree flexion angle. 
The data was recorded at 100 Hz and included joint position, velocity, number 
of cycles and duration of the task. Time to fatigue (TTF) and the rate (calculated by 





The TTF was used to calculate the odds ratio (OR) to describe the association 
between acute KT application and time to fatigue. Table 3 and Equation 1 explain 
the calculation of the odds ratio, including the parameters required for each leg. The 
odds ratio result was determined by the scale presented in Figure 4.   
Table 3:  TTF performance odds ratio table 
TTF Treatment leg Control Leg 
TTF Increased a b 








                                                               Eq 1 
a = number of subjects with increased TTF on the treatment leg 
b = number of subjects with increased TTF on the control leg 
c = number of subjects with no increase in TTF on the treatment leg 
d = number of subjects with no increase in TTF on the control leg 
 
When 0<OR<1 When 1<OR<∞ 
 No effect or negative 
association 
Positive association with 
KT 
 
Figure 4: Odds ratio scales 
 
 The relative risk (RR) considered the time factors. Therefore, relative risk was 
calculated to examine the effect of duration of KT application (after 24 hours, 48 




hours, and 72 hours of wearing). Table 4 and Equation 2 explain the calculation of 
the relative risk, including the parameters required for each leg. The relative risk 
result was determined by the scale presented in Figure 5. 
 
Table 4: TTF performance relative risk table 
TTF TTF Increased TTF Not Increased 
Treatment leg a b 
Control Leg c d 
 





                                                Eq 2 
a = number of subjects with increased TTF on the treatment leg 
b = number of subjects with no increase TTF on the treatment leg 
c = number of subjects with increase in TTF on the control leg 
d = number of subjects with no increase in TTF on the control leg 
 
When 0<OR<1 When 1<OR<∞ 
 Negative association with 
duration of KT wearing 
Positive association with 
duration of KT 
Figure 5: Relative risk scales 
 The rate of knee flexion/extension was calculated by dividing the total number 
of cycles by time to fatigue or total task time (Eq 3). All three parameters are related, 
and to determine the true meaning of any changes all three must be considered. For 
example, TTF may increase, but if no change occurred in the number of cycles, it 









                                        Eq 3 
 As with TTF, odds ratio and relative risk were used to discuss the acute KT 
application and the duration of KT wearing. 
 The percent change of TTF and rate was calculated to normalize the data and 
unify the scale. The percent change is necessary when discussing the comparison 
between legs (Eq 4), since the percent change explains the TTF or rate data 
increase or decrease more directly (Eq 5, Eq 4).  
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝐶ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑇𝑇𝐹 =
 𝑇𝑇𝐹 𝐷𝑎𝑦𝑖 
 𝑇𝑇𝐹 𝐷𝑎𝑦2
                               𝑖 = 3, 4, 5, 6, 7, 8        Eq 4     
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝐶ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑅𝑎𝑡𝑒 =
𝑅𝑎𝑡𝑒 𝐷𝑎𝑦𝑖 
 𝑅𝑎𝑡𝑒 𝐷𝑎𝑦2
                            𝑖 = 3, 4, 5, 6, 7, 8        Eq 5   
 
 2.3.2 Near-infrared spectroscopy (NIRS): The EQUANOX 7600 (Nonin 
Medical Inc., MN) two channel Near Infrared System (NIRS) was used to measure 
the regional muscle oxygen saturation (rSO2) and is shown in Figure 6. Two sensors 
were placed on the Vastus Lateralis (VL) and Vastus Medialis (VM) muscles, which 
are the two largest muscles of the quadriceps muscle group as depicted in Figure 7. 
Before placing the electrodes, the sensor placement area was cleaned with alcohol, 
and after placement the sensors were secured with a bandage to prevent movement.  
 NIRS data was recorded at a rate of 0.25 Hz and was represented as percent 
of rSO2 at any given time. The rSO2 recordings during the fatiguing isotonic knee 




beginning to the end.  The NIRS data normalization was done as follows: 
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑟𝑆𝑂2 =
𝑟𝑆𝑂2 𝑙𝑒𝑣𝑒𝑙𝑠 𝑜𝑛 𝐷𝑎𝑦 𝑖
𝑟𝑆𝑂2 𝑙𝑒𝑣𝑒𝑙𝑠 𝑎𝑡 𝑡ℎ𝑒 𝑏𝑒𝑔𝑖𝑛𝑛𝑖𝑛𝑔 𝑜𝑓 𝑡𝑟𝑖𝑎𝑙 𝑜𝑛 𝐷𝑎𝑦 𝑖
                             
   𝑖 = 1,2,3,4, 5, 6, 7, 8            Eq 6 
After normalizing the data, the trends and the minimum rSO2 level were 
extracted for each trial. Instead of using the time when the minimum drop occurred to 
determine time to fatigue, the percentage of the TTF previously described was 
calculated for further analysis (Eq 7).  
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑇𝑇𝐹 𝑡𝑜 𝑚𝑖𝑛𝑖𝑚𝑢𝑚 𝑟𝑆𝑂2 𝑙𝑒𝑣𝑒𝑙𝑠 =
𝑇𝑖𝑚𝑒 𝑡𝑜 𝑚𝑖𝑛𝑖𝑚𝑢𝑚 𝑟𝑆𝑂2  𝐷𝑎𝑦𝑖 
𝑇𝑇𝐹 𝐷𝑎𝑦𝑖
   
          𝑖 = 1,2,3,4, 5, 6, 7, 8        Eq 7 
 






Figure 7: NIRS sensor placement 
 
 2.3.3 Video recording: 
 All the experiments were recorded using a standard digital video camera 
(Sony, Japan) in order to visually assess the subjects’ performance. Some subjects 
did not perform full cycles at the end of their trial and the video recording combined 




 2.5.1 Statistical Analysis 
 One of the methods that could assess the outcome performance in this 




time series could explain the trend rising or descending; the equation below is the 
time series (Eq 8). The time series can forecast future performance, and check the 
data point trends already collected (C. Chatfield, 2016; D. Montgomery, 2015). Time 
series analysis is commonly used in economic and biology studies. The coefficient β 
is the slope of the trend, and the β comparison calculated by paired t-test indicates 
how the exercise performance changes. Time series is used to investigate whether 
Hypothesis 1 and 2 are rejected or failed to reject. 
𝑌𝑡 = 𝑦0  +  𝛽 ∗ 𝑡                    𝑡 = 𝐷𝑎𝑦 1, 2, 3, … … , ∞                                        Eq 8 
β= The slope (coefficient) of the time series 
y0= Initial point of response 
Yt= The forecasted response on Day t  
The outliers were identified using Eqs 9-11. 
𝐼𝑄𝑅 = 𝑄3 − 𝑄1                                                                                            Eq 9 
𝐿𝑜𝑤 𝑂𝑢𝑡𝑙𝑖𝑒𝑟 𝑃𝑜𝑖𝑛𝑡 = 𝑄1 − (1.5 × 𝐼𝑄𝑅)                                                       Eq 10 
𝐻𝑖𝑔ℎ 𝑂𝑢𝑡𝑙𝑖𝑒𝑟 𝑃𝑜𝑖𝑛𝑡 = 𝑄3 + (1.5 × 𝐼𝑄𝑅)                                                     Eq 11 
Interquartile Range: IQR 
First Quartile: Q1 
Third Quartile: Q3  
Paired t-test was used for statistical analysis while keeping a subject as a 
block.  Confidence was set at 95%.   To answer the hypotheses a, D2 and D3 are 




application duration will be interpreted by the comparison with D3 to 24 hours, 48 
hours, and 72 hours (D4 to D6).  To explain hypothesis c (residual effect), D7 
compared to D6 and D2 will be calculated to evaluate the residual effect. 
 One-sided Wilcoxon sign tests were utilized for hypotheses 1 and 2 to answer 
whether the KT will enhance the TTF or rate performance, because both 
performance data are not normally distributed. On the other hand, Hypothesis 3 
investigated whether or not the KT would increase the sitting baseline. Therefore, 
one-tailed paired t-test (sitting baseline data passed the normality test) has been 
selected in this study. Hypotheses 4 and 5 were assessed using a two-tailed paired 
t-test (minimum rSO2 and time to minimum rSO2 level in the trial data had to pass the 
normality test) because it is expected that KT will affect muscle oxygenation, but the 





Chapter 3 Results 
3.1 Fatiguing of Isotonic Knee Flexion Extension Exercise 
 3.1.1 Time to Fatigue (TTF):   
  Effects of KT were calculated by comparing the changes within TTF in the 
treatment and control leg of each subject across days of KT application.  
Performance could have either increased or not increased (no change between days 
or decreased both days).  A subject was considered to have enhanced performance 
if there was an increase in the TTF only within the treatment leg. Comparisons 
between D3 and D2 captured the acute effects of KT; whereas, comparisons 
between D3 and D4-D6 investigated the effects of duration of KT application.  
In this study, an enhancement in the treatment leg’s performance occurred in 
only 2 subjects (14%) between D3 and D2 (Table 5).  Nine of the 14 subjects’ (64%) 
performance either increased or not increased in both legs.  The odds ratio (OR) of 
0.75 (Figure 8) indicates that the odds of observing an increase in TTF is less for the 
treatment leg than the control leg. Furthermore, the results (Figure 9) show that the 
subjects did not experience a statistically significant increase in TTF upon immediate 
application of KT (p=0.265). 
 
Table 5: Number of subjects in each TTF response category based on acute KT application 
Changes in TTF between D3 and D2 Number of subjects 
Increased in both legs 5 
No increase in both legs 4 
Treatment leg increased 2 
Control leg increased 3 
















































Figure 9: The acute effect of KT application on TTF in the treatment leg. ♦ indicates an outlier. * indicates 




 The results for the duration of KT application are based on comparing leg 
performance between D3 and after 24 hours (D4), 48 hours (D5), and 72 hours (D6) 
of wearing KT (Figure 11). After 24 hours of KT application, within the treatment leg 
of 3 subjects, the TTF increased (21%).  For 10 of 14 subjects (71%), the TTF either 
increased or not increased in both the treatment and control leg after 24 hours 
application of KT. No subject saw an enhancement only in the treatment leg 48 
hours after KT application (D5).  On this same day, similar performance (either 
increased or not increased) was noted for both legs in 86% of the subjects (12 of the 
14 subjects).  The results after 72 hours of KT application indicated that 9 of the 
subjects (64%) have a similar trend for both legs (either increased or not increased), 
and performance in 2 of the 14 subjects (14%) was better for the treatment leg but 
TTF decreased in the control leg. Table 6 quantifies the dose-response relationship 
between duration of KT application and leg performance.  The relative risk shows 
that enhanced performance is more likely in the treatment leg only after 24 hours KT 
application (RR=1.286) (Figure 10). Statistical test results indicate no significant 
increase in TTF after 24 (p=0.235), 48 (p=0.063) or 72 hours (p=0.139) of KT 
application (Figure 11). 
Table 6: Number of subjects in each TTF response category for each 24 hour period of KT application through 
D6 (72 hours after KT application) 
Changes in TTF from D3  
Number of subjects 
D4-D3 D5-D3 D6-D3 
Increased in both legs 6 9 6 
No Increase in both legs 4 3 3 
Treatment leg increased 3 0 2 
Control leg increased 1 2 3 

















































Figure 11: Box plot of TTF throughout the duration of KT application in treatment leg. ♦ indicates an outlier. * 





 Days 7 and 8 (24 and 48 hours after KT removed) were tested to consider the 
residual effects of KT, if any. No residual effects of KT were expected.  In other 
words, The TTF was expected to have a decrease at 24 hours after tape was 
removed (D7 compared to D6) and observe similar results as those on D2. In the 
treatment leg on D7 to D2 and D7 to D6, the TTF marked increase on both days (D7 
to D2: p=0.018, Power=99.6%) (D7 to D6: p=0.005, Power=92.5%). However, when 
D7 is compared with D6, 10 of 13 subjects’ (77%) TTF increase/decrease at the 
same time, and 3 of the subjects might increase because of KT residual effect. In 
comparison of D7 to D2, 12 of 13 subjects’ (92%) TTF increased/decreased in both 
legs at the same time. Furthermore, 10 of 13 subjects (77%) show TTF increased on 
both legs when compared with D2 (Table 7). Additionally, the control leg was used to 
support if the increase found for the treatment leg was due to a residual effect. D7 to 
D6 control leg comparison has insignificant increase (p=0.38, Power=38.0%), but 
TTF on D7 significantly increased when compared to D2 (p=0.005, Power=100.0%) 
(Figure 12).  
Table 7:  Number of subjects in the category of TTF changes based on the residual of KT application results. D7 
(the day after 24 hours KT removed) compare to D6 (The last day of test with KT application), D2 (A day before 
KT application wearing) 
Changes in TTF from D7 
Number of subjects 
D7-D6 D7-D2 
Increased in both legs 7 10 
No increase in both legs 3 2 
Treatment leg increased 3 0 
Control leg increased 0 1 








 The root cause of TTF increasing on D7 could be explained by comparing D2 
to other days. The results indicate that both legs’ TTF increased when extending the 
experiment day (Table 8). The most significant increase in treatment leg (p=0.005) 
and control leg (p=0.003) both happened on D5, which is also the day that both legs 
show the TTF significantly increased. Both the treatment leg and control leg results 
show that TTF significantly increased continuously from D5 to D8. According to the 
D2 comparison to other days’ results, similar trends were shown in the treatment and 




















Figure 12: Box plot showing the TTF on D2, D6, and D7 for both the control and treatment leg. ♦ indicates an 
outlier. * indicates statistical significance between median TTF (indicated by horizontal line within bar) for D7 




Table 8: The results of Wilcoxon analysis in D2 (no KT effect) compare to D3 through D8 (the day with KT and 
after KT removed) to answer the residual effect of TTF is caused by KT or other factor. 





in TTF    
Range 












D3 -2 20 0.265 33.6% 1 33 0.550 7.0% 
D4 3 15 0.062 76.5% 5 20 0.265 63.1% 

































* indicates statistical significance between median TTF.  
▲ presents the Power is greater than 80% 
 Time series analysis is another method to show any potential learning effect. 
According to the Time Series Equation (Eq 8), coefficient β represents the slope of 
the trend. The slope describes whether or not the change between two legs is the 
same. In this study, the paired t-test of the estimated slope parameters results (data 
table please refer to appendices Table A- 5) indicate that the changes in TTF data 
have no significant increases when comparing the control leg and treatment leg 
(p=0.165). As a result, the time series’ slopes show that two legs have similar 
performance during the long-term fatiguing exercise experiment.  
 
 3.1.2 Rate of Flexion/Extension:  
 The acute KT application result in raw data (Table 9) shows that 5 of the 
subjects’ (36%) rate increase might have been because of KT application when 
compared with Day 2 (before KT application). Either the rate increased or not 
increased in both legs for 6 of 14 subjects (43%) upon immediate application of KT 




may enhance the rate by acute KT application, the OR was 1.8 (Figure 13). Figure 14 
indicates that an increased rate was observed more in the treatment leg on D3 than 
in the control leg.  The Wilcoxon test results (Figure 14) indicate a statistically 
significant increase in leg performance on Day 3 when compared to D2 (p=0.027), 
but note the low Power for this result. 
Table 9: Number of subjects in each category of rate response based on acute KT application 
Changes in rate between D3 and D2  Number of subjects 
Increased in both legs 4 
No increase in both legs 2 
Treatment leg increased 5 
Control leg increased 3 
Total subjects 14 
 
 





























 Secondly, to assess the duration of KT application, Day 3 was selected to test 
the enhancement of rate after 24, 48, and 72 hours of KT application (Table 10). The 
rate increased in only the treatment leg of 1 subject 24 hours after KT application 
and either increased or not increased in both legs of 11 subjects (79%). After 48 
hours of wearing KT, the rate increased in only the treatment leg for 2 of the 14 
subjects (14%), and either increased or not increased in 8 of the subjects. A similar 
observation was noted 72 hours after KT application.  Rate increased in the 
treatment leg in 2 subjects and either increased or not increased in 9 subjects. All 
the RR values are less than 1 (24 hours RR=0.875, 48 hours RR=0.818, 72 hours 
RR=0.89), indicating that an increased rate is less likely to occur in the treatment leg 
the longer the application of KT (Figure 15). These results are further supported by 





























Figure 14: Box plot of the rate on D2 and D3 for both the treatment and control legs. ♦ indicates an outlier. * 




a statistically significant rate increase in the duration of KT application (24 hours 
p=0.556, 48 hours p=0.094, 72 hours p=0.201). 
Table 10: Number of subjects in each category of rate response for each 24 hour period of KT application 
through D6 (72 hours after KT application) 
Changes in rate from D3  
Number of subjects 
D4-D3 D5-D3 D6-D3 
Increased in both legs 6 7 6 
No increase in both legs 5 1 3 
Treatment leg increased 1 2 2 
Control leg increased 2 4 3 





























 The residual effect was tested by D7 compared to D6 and D2. The raw data 
result on D7 compared to D6 was expected to show the rate increased continuously 
or retained the same rate as D6. Results were collected for 13 of the 14 subjects.  
Table 11 depicts the results for these 13 subjects. In comparison to D2, 9 of the 13 
subjects (69%) show that the rate either increased or not increased in both legs and 
increased only in the treated leg for 3 of the 14 subjects (Table 11). The Wilcoxon 
signed ranking test results present that after taking off the KT for 24 hours, there was 
no significant increase observed in rate when compared to D6 (p=0.447), and the 
median difference being 0 tells that the rate on D7 is similar to D6. From another 
point of view, the result on D7 compared with D2 (Figure 17) not only shows the rate 
statistically significantly increased (p=0.015), but also has 88.0% of Power to support 

























Figure 16: Box plot of rate for D3, D4, D5, and D6. ♦ indicates an outlier. * indicates statistical significance 




whether the KT had a residual effect in rate on treatment leg. 
 
Table 11: Number of subjects in each change in   rate category based on the residual of KT application results. 
D7 (the day after 24 hours KT removed) compare to D6 (The last day of test with KT application), D2 (A day 
before KT application wearing) 
Changes in rate from D7 
Number of subjects 
D7-D6 D7-D2 
Increased in both legs 3 7 
No increase in both legs 3 2 
Treatment leg increased 3 3 
Control leg increased 4 1 
Total subjects 13 13 
 
 The control leg D7 compare to D6 (Figure 17) shows that the increase is 
statistically insignificant, which is similar to the treatment leg. In comparison of D7 to 
D2, Wilcoxon signed ranking test result present that D7 has a significant increase. 
However, the Power shows that it only has 63.4% chance of an increase in rate as a 
result of residual effect. Therefore, D2 compared to other days is evidence to explain 





Figure 17 : Box plot of rate for D2, D6, and D7 for both the treatment and control leg.  ♦ indicates an outlier.  * 
indicates statistical significance between median rate (indicated by horizontal line within bar) for D7 compare to 
D6 and D2 in treatment leg and control leg 
 
 For D2 compared to other Days’ results, both the treatment leg (p=0.008) and 
control leg (p=0.018) have the smallest p on D7. The treatment leg Power begins to 
be greater than 80% from D7 (Power=91.8%). Nevertheless, the control legs’ largest 
Power is on D7 and is equal to 71.7%. According to the trends in the two legs, the 
rate is increasing every day (Table 12) for both. Hence, the last step is to show 
whether the rate increase is due to KT or another effect, and comparing the time 






































Table 12: The results of Wilcoxon analysis in D2 (no KT effect) compare to D3 through D8 (the day with KT and 
after KT removed) to answer the residual effect is caused by KT or other factor 
Rate on D2 compare to other Days 
















D3 0.039 0.239 0.027* 66.9% 0.002 0.2 0.663 10.1% 
D4 0.027 0.181 0.046* 59.9% 0.015 0.162 0.242 18.0% 
D5 0.032 0.322 0.027* 65.1% 0.02 0.179 0.147 29.2% 
D6 0.049 0.403 0.021* 72.3% 0.023 0.137 0.084 35.5% 
D7 0.066 0.349 0.008* 91.8%▲ 0.044 0.127 0.033* 63.4% 
D8 0.095 0.376 0.008* 93.3%▲ 0.057 0.259 0.018* 71.7% 
* indicates statistical significance between median rate 
▲ presents the Power is greater than 80% and the p is truly significant 
 
 The same time series analysis that was performed on TTF was also done for 
rate. The time series analysis can assess if the treatment leg had better rate 
performance than the control leg. The results (data refer to appendices Table B- 5) 
show that there is an insignificant increase in rate (p=0.741). In addition, the Time 
Series’ slope test shows that the two legs have similar performance during the long-
term fatiguing exercise experiment. 
 
3.2 Muscle Oxygenation 
 Every subject utilizes the muscles in a different way. In this study, 8 subjects 
have a rapid decrease in muscle oxygenation (rSO2) for both legs at the beginning of 
the testing and slow recovery throughout the testing (Figure 34). The other subjects 
have a constant reduction in muscle oxygenation until the end of the trial.  
 3.2.1 Sitting baseline rSO2 level: 




subjects (76.92%) had an increase in Sitting Baseline on D3 in comparison to D2 
(Table 13). The OR=6.00 means that KT has a positive association with an increase 
in sitting baseline rSO2 levels (Figure 18). The acute KT application did not 
significantly increase the sitting baseline rSO2 levels on the treatment leg VM muscle 
(p=0.062) (Figure 19). 
Table 13: Number of subjects in each category in VM muscle oxygenation sitting baseline based on acute KT 
application 
Changes in VM muscle sitting baseline between D3 and D2 Number of subjects 
Increased in both legs 5 
Decreased in both legs 3 
Treatment leg increase 5 
Control leg increased 0 
Total subjects 13 
 
 
Figure 18: Odds ratio for association between the treatment and control leg VM muscles and changes in muscle 

























Figure 19: Box plot of VM sitting baseline rSO2 levels for D2 and D3 in the treatment leg. ♦ indicates an outlier. * 
indicates statistical significance between mean sitting baseline (indicated by horizontal line within bar) for D2 and 
D3 
 
 Analysis regarding the duration of KT application (Table 14) revealed that 8 
subjects’ sitting baseline levels decreased on D4 from D3. By D5, 11 subjects’ sitting 
baseline decreased (78.57%) from D3, but on D6 the subjects who decreased their 
sitting baseline went down to 10 (71.43%). Additionally, the RR provides evidence 
that extending the duration of KT application might not increase the sitting baseline 
rSO2 levels, since the values are all less than 1 (D4-D3 RR=0.857, D5-D3 
RR=0.333, D6-D3 RR=0.4) (Figure 20). Insignificant increases in treatment leg VM 
muscle sitting baseline (Figure 21) were observed when D3 was compared with 
other taped days (24 hours p=0.884, 48 hours p=0.993, 72 hours p=0.806). In 
addition, RR and mean difference in paired t-test results all show that the longer 


























 Table 14: Number of subjects in each category of VM muscle sitting baseline response for each 24 hours period 
of KT application through D6 (72 hours after KT application) 
Changes in VM muscle sitting baseline from D3 
Number of subjects 
D4-D3 D5-D3 D6-D3 
Increased in both legs 3 2 3 
Not increased in both legs 4 4 3 
Treatment leg increase 3 1 1 
Control leg increased 4 7 7 
Total subjects 14 14 14 
 
 

























Figure 21: Box plot of VM muscle oxygenation sitting baseline for D3, D4, D5, D6.  ♦ indicates an outlier.  * 
indicates statistical significance between mean muscle oxygenation sitting baseline (indicated by horizontal line 
within bar) for D3 to D4, D5, D6 
 
 The residual effect from KT can be observed by analyzing D7. On D7, 9 of the 
subjects had both legs either increase the sitting baseline levels or did not increase 
their levels in comparison to D6 (Table 15). The comparison between D6 and D7 
shows insignificant increase (p=0.399) (Figure 22). Furthermore, there is no 
statistical difference between D7 compared with D2, which shows there is no 
residual effect (p=0.399). 
Table 15: Number of subjects in each category of VM muscle oxygenation sitting baseline changes based on the 
residual of KT application results. D7 (the day after 24 hours KT removed) compare to D6 (The last day of test 
with KT application), D2 (A day before KT application wearing) 
Changes in VM muscle sitting baseline from D7 
Number of subjects 
D7-D6 D7-D2 
Increased in both legs 4 2 
Not increased in both legs 5 3 
Treatment leg increase 3 3 
Control leg increased 1 4 


























Figure 22: Box plot of VM sitting baseline muscle oxygenation for the treatment legs on D2, D6, and D7. ♦ 
indicates an outlier. * indicates statistical significance between mean VM muscle oxygenation sitting baseline 
(indicated by horizontal line within bar) for D7 compare to D6 and D2 in treatment leg VM muscles 
 
 Vastus Lateralis (VL): The results from acute KT application on D3 shows that 
9 of 14 subjects (69%) increase or did not increase in both of their legs at the same 
time in comparison to D2. 23% of subjects VL sitting baseline increased from D2 
only on the treatment leg (Table 16). The OR indicates that the acute KT application 
is associated with VL sitting baseline increase (OR=2.13) (Figure 23). The 
comparison of D3 to D2 in treatment leg VL muscle shows that there is a statistically 
significant increase in sitting baseline rSO2 levels with acute KT application 
(p=0.045), but the Power of the test shows only 64.155% chance of an increase in 

























Table 16: Number of subjects in each category of VL muscle oxygenation sitting baseline changes based on 
acute KT application 
Changes in VL muscle sitting baseline between D3 and D2  Number of subjects 
Increased in both legs 5 
Not increased in both legs 4 
Treatment leg increased 3 
Control leg increased 1 
Total subjects 13 
 
 
Figure 23: Odds ratio for association between treatment and control leg and changes in VL muscle oxygenation 























Figure 24: Box plot of VL muscle oxygenation sitting baseline for D2 and D3 in the treatment leg. ♦ indicates an 
outlier. * indicates statistical significance between mean sitting baseline (indicated by horizontal line within bar) 
for D2 and D3 
 
 The effect of duration of KT application shows that after 24 hours of KT 
application, 6 of 14 subjects (43%) VL sitting baseline increased only on the 
treatment leg. After wearing KT for 48 hours, 10 of the subjects (71%) increase/did 
not increase their sitting baseline levels in both legs at the same time. After 72 hours 
KT application, 5 subjects (36%) increased only on the treatment leg, and 4 subjects 
(29%) only increase in the control leg. RR results show that all the values are greater 
than 1, which means that KT application has positive association with VL increasing 
sitting baseline levels (Figure 25). However, the RR consistently decreases from 24 
hours to 72 hours (24 hours RR=1.8, 48 hours RR=1.286, 72 hours RR=1.14) 
showing that the duration of KT application reduces this association between KT and 
VL sitting baseline. The duration of KT application results (Figure 26) show no 























(p=0.600) KT application.  
 
Table 17: Number of subjects in each category of VL muscle oxygenation sitting baseline changes for each 24 
hours period of KT application through D6 (72 hours after KT application) 
Changes in VL muscle sitting baseline from D3 
Number of Subjects 
D4-D3 D5-D3 D6-D3 
Increased in both legs 3 6 3 
Not increased in both legs 3 4 2 
Treatment leg increased 6 3 5 
Control leg increased 2 1 4 
Total subjects 14 14 14 
 
 




























Figure 26: Box plot of VL muscle oxygenation sitting baseline for D3, D4, D5, D6. ♦ indicates an outlier. * 
indicates statistical significance between mean muscle oxygenation sitting baseline (indicated by horizontal line 
within bar) for D3 to D4, D5, D6 
 
 D7 compare to D6 and D2 can define the residual effect of KT application. 
According to D7 compared to D6, 10 of 13 subjects (77%) had both of their legs 
either increase or did not increase their VL sitting baseline level (Table 18). Only 1 of 
the subjects shows a residual effect, with the treatment leg increasing VL sitting 
baseline level from D6. When D7 is compare to D2, half of the subjects 
simultaneously increased or did not increased their sitting VL baseline rSO2 levels 
for both legs. 4 of the subjects (31%) had a residual effect from KT application 
because only the treatment leg increased on D7. There were no statistically 
significant changes between D7 and D2 as well as between D7 and D6 for VL sitting 




























Table 18: Number of subjects in each category of VL muscle oxygenation sitting baseline changes based on the 
residual of KT application results. D7 (the day after 24 hours KT removed) compare to D6 (The last day of test 
with KT application), D2 (A day before KT application wearing) 
Changes in VL muscle sitting baseline from D7 
Number of subjects 
D7-D6 D7-D2 
Increased in both legs 5 4 
Not increased in both legs 5 2 
Treatment leg increased 1 4 
Control leg increased 2 2 
Total subjects 13 12 
 
 
Figure 27: Box plot of treatment leg VM muscle oxygenation sitting baseline for D2, D6, and D7. ♦ indicates an 
outlier. * indicates statistical significance between mean VM muscle oxygenation sitting baseline (indicated by 
horizontal line within bar) for D7 compare to D6 and D2 in treatment leg VM muscles 
 
3.2.2 Minimum rSO2 level: 
 Vastus Medialis (VM): The results for acute KT application shows that 4 
subjects (31%) had changes in minimum rSO2 levels between D3 and D2 in different 
directions for both of their legs. 9 of 13 subjects (69%) had VM minimum rSO2 levels 

























subjects experienced a statistically significant change in the VM minimum rSO2 
levels immediately after putting on the KT (p=0.022) (Figure 28). 
Table 19: Number of subjects in each category of VM minimum rSO2 levels changes based on acute KT 
application 
Changes in VM minimum rSO2 levels between D3 and D2 Number of subjects 
Increased in both legs 6 
Decreased in both legs 3 
Treatment leg increased 3 
Control leg increased 1 
Total subjects 13 
 
 
Figure 28: Box plot of VM muscles of minimum rSO2 levels on D2 and D3 for both the treatment and control leg. ♦ 
indicates an outlier. * indicates statistical significance between mean minimum rSO2 levels (indicated by 
horizontal line within bar) for D2 and D3. 
 After 24 hours KT application, 7 subjects (54%) showed that the treatment 
and control leg either increase or decrease in opposite directions for their VM 
minimum rSO2 levels, and 2 of the subjects had increases for the treatment leg, and 
the other 3 subjects show that KT will decreased the VM minimum rSO2 levels for 




























increases for one leg and decreases for their other leg. 5 of those subjects had an 
increase in minimum rSO2 levels for the treatment leg. After 72 hours of wearing KT, 
10 subjects (71%) had their control and treatment leg minimum rSO2 levels change 
in different directions when compared to D3 (Table 20). The paired t-test results 
demonstrate that the duration of KT application will not change the effect of KT on 
minimum rSO2, 24 (p=0.384), 48 (p=0.241), 72 hours (p=0.741) (Figure 29). 
Table 20: Number of subjects in each category of VM minimum rSO2 changes for each 24 hours period of KT 
application through D6 (72 hours after KT application) 
Changes in VM minimum rSO2 levels from D3 
Number of subjects 
D4-D3 D5-D3 D6-D3 
Increased in both legs 3 2 2 
Decreased in both legs 4 5 2 
Treatment leg increased 2 5 4 
Control leg increased 3 2 5 
No change 1* 0 1** 
Total subjects 13 14 14 
* control leg VM minimum rSO2 levels no change, treatment leg VM minimum rSO2 levels 
increased 







Figure 29: Box plot of VM minimum rSO2 levels in the treatment leg for D3, D4, D5, and D6. ♦ indicates an outlier. 
* indicates statistical significance between mean minimum rSO2 levels (indicated by horizontal line within bar) for 
D3 to D4, D5, D6 
 
 The residual effect was checked by D7 compare to D2 and D6. In the raw 
data grouping result, none of subject has no change between days. 7 of the subjects 
(54%) might experience the KT residual effect 24 hours after removal. When 
comparing D7 to D2, 5 subjects (42%) have residual possible effect (Table 21). 
Nevertheless, the paired t-test results show that the minimum rSO2 have insignificant 
differences between D7 and D2 (p=0.215). The D7 and D6 comparison also presents 
that insignificant change was discovered between the two days (p=0.314) (Figure 
30). The results all indicate that KT will not have residual effect in minimum rSO2 




























Table 21: Number of subjects’ in each category of VM minimum rSO2 changes based on the residual of KT 
application results. D7 (the day after 24 hours KT removed) compare to D6 (The last day of test with KT 
application), D2 (A day before KT application wearing) 
Changes in VM minimum rSO2 levels from D7 
Number of Subjects 
D7-D6 D7-D2 
Increased in both legs 2 4 
Decreased in both legs 4 3 
Treatment leg increased 2 2 
Control leg increased 5 3 
Total subjects 13 12 
 
 
Figure 30: Box plot of the treatment leg VM minimum rSO2 levels on D2, D6, D7. ♦ indicates an outlier. * indicates 
statistical significance between mean VM minimum rSO2 levels (indicated by horizontal line within bar) for D7 
compare to D6 and D2 in treatment leg VM muscles 
 
 Vastus Lateralis (VL): The immediate KT application does not show a 
difference in raw data grouping results, because 9 of the subjects (69%) 
increase/decrease the VL minimum rSO2 in both legs (Table 22). The acute KT 
application does not show a significant difference (p=0.182) in the VL minimum rSO2 


























Table 22: Number of subjects in each category of changes in VM minimum rSO2 levels based on acute KT 
application 
Changes in VL minimum rSO2 levels between D3 and D2 Number of subjects 
Increased in both legs 7 
Decreased in both legs 2 
Treatment leg increased 3 




Figure 31: Box plot of the treatment leg VL minimum rSO2 levels for D2 and D3. ♦ indicates an outlier. * indicates 
statistical significance between mean minimum rSO2 levels (indicated by horizontal line within bar) for D2 and D3 
 
 Secondly, the duration of KT application effectiveness were examined by D3 
compared with D4 through D6. When D4 is compared to D3, 10 of the subjects 
(77%) increase/decrease VL minimum rSO2 levels in both legs. After 48 hours KT 
application, 50% of subjects’ treatment leg VL minimum rSO2 changed differently 
from the control leg.  When D6 is compared to D3, 10 subjects (71%) had the 























raw data grouping, the duration effect of KT application cannot be explained. 
Furthermore, the paired t-test results show that no significant difference was 
discovered in 24 (p=0.297), 48 (p=0.379), or 72 hours (p=0.321) after KT application 
(Figure 32). 
 
Table 23: Number of subjects in each category of changes in VL minimum rSO2 levels for each 24 hours period 
of KT application through D6 (72 hours after KT application) 
Changes in VL minimum rSO2 levels from D3 
Number of subjects 
D4-D3 D5-D3 D6-D3 
Increased in both legs 3 2 6 
Decreased in both legs 7 5 4 
Treatment leg increased 1 4 1 
Control leg increased 2 3 3 
Total 13 14 14 
 
 
Figure 32: Box plot of VL minimum rSO2 levels in the treatment leg for D3, D4, D5, and D6. ♦ indicates an outlier. 
* indicates statistical significance between mean minimum rSO2 levels (indicated by horizontal line within bar) for 


























 D7 comparison could explain the KT residual effect. The raw data show that 7 
subjects (54%) might have a residual effect since the two legs changed in different 
ways. Nevertheless, since the same numbers of subjects were found to have the 
treatment leg and control leg minimum rSO2 value change in the same directions, 
the residual effect may not exist. The paired t-test between D7 and D2 shows that 
the two days values are statistically insignificantly different (p=0.820). The result for 
D7 compared to D6 also shows that VL minimum rSO2 levels have insignificant 
differences (p=0.125). 
 
Table 24: Number of subjects in each category of changes in VL minimum rSO2 levels based on the residual of 
KT application results. D7 (the day after 24 hours KT removed) compare to D6 (The last day of test with KT 
application), D2 (A day before KT application wearing) 
Changes in VM minimum rSO2 levels from D7 
Number of Subjects 
D7-D6 D7-D2 
Increased in both legs 2 3 
Decreased in both legs 4 2 
Treatment leg increased 1 1 
Control leg increased 5 6 
No change 1* 0 
Total subjects 13 12 






Figure 33: Box plot of treatment leg VL minimum rSO2 levels for D2, D6, and D7. ♦ indicates an outlier. * 
indicates statistical significance between mean VL minimum rSO2 levels (indicated by horizontal line within bar) 
for D7 compare to D6 and D2 in treatment leg VL muscles 
 
 An example of muscle oxygenation over a trial is shown in Figure 34 for the 
treatment leg of subject 5 on D3. The rSO2 level for the VL muscle drops rapidly at 
the beginning of the trial and then starts to recover. The VM muscle minimum rSO2 
levels are greater than the VL, which presents a comparative analysis for the 
minimum drop in rSO2 levels for both muscle (VL and VM) in the taped and control 

























Figure 34: Example of muscle oxygenation trial (Subject 5, treatment leg, on D3) 
 
 3.2.3 Time to minimum rSO2 level: 
   Vastus Medialis (VM): The acute KT application might influence the treatment 
leg VM time to minimum rSO2, because 8 of 13 subjects (62%) show that the 
treatment leg changes differently from the control leg. Except for 1 subject who had 
no change in the treatment leg, 4 of the subjects have positive/negative changes 
simultaneously on both legs, and 4 of the subjects had an increase in the treatment 
leg, but a decrease in the control leg; and another 4 subjects decreased in the 
treatment leg, but had an increase in the control leg (Table 25). The treatment leg 
paired t-test result has no statistically significant difference to explain that the acute 




























Table 25: Number of subjects in each category of changes in VM time to minimum rSO2 based on acute KT 
application 
Changes in VM time to minimum rSO2 levels between 
D3 and D2  
Number of Subjects 
Increased in both legs 3 
Decreased in both legs 1 
Treatment leg increased 4 
Control leg increased 4 
No change 1* 
Total subjects 13 
* control leg time to minimum rSO2 levels decreased, treatment leg time to minimum rSO2 
levels no change 
 
 
Figure 35: Box plot of treatment leg VM time to minimum rSO2 levels for D2 and D3. ♦ indicates an outlier. * 
indicates statistical significance between mean time to minimum rSO2 levels (indicated by horizontal line within 
bar) for D2 and D3 
 
 Despite the acute KT application having no significant effect in VM time to 
minimum rSO2 levels, the duration of KT application may still cause a change. Based 
on the raw data after 24 hours of KT application, 9 of the subjects (64%) 



























14 subjects (57%) both legs increase/decrease. And 72 hours of KT application 
shows 7 subjects (50%) time to minimum rSO2 in the two legs increase/decrease 
together (Table 26). Furthermore, the duration of KT application comparison results 
show no statistically significant differences between acute KT application and other 
KT application days (24 hours p=0.613, 48 hours p=0.326, 72 hours p=0.253). After 
48 hours of KT application, the time to minimum rSO2 levels does occur earlier 
(mean difference =-0.062). 
Table 26: Number of subjects in each category of changes in VM time to minimum rSO2 levels for each 24 hours 
period of KT application through D6 (72 hours after KT application) 
Changes in VM time to minimum rSO2 levels from D3 
Number of subjects 
D4-D3 D5-D3 D6-D3 
Increased in both legs 4 3 3 
Decreased in both legs 5 5 4 
Treatment leg increased 3 2 4 
Control leg increased 1 4 1 
No change 0 0 
1* 
1** 
Total subjects 13 14 14 
* control leg time to minimum rSO2 levels decreased, treatment leg time to minimum rSO2 
levels no change 
** control leg time to minimum rSO2 levels increased, treatment leg time to minimum rSO2 






Figure 36: Box plot of VM time to minimum rSO2 for D3, D4, D5, and D6. ♦ indicates an outlier. * indicates 
statistical significance between mean VM time to minimum rSO2 levels (indicated by horizontal line within bar) for 
D3 to D4, D5, D6 
 
When D7 is compared to D6, the results explain the residual effect. Table 27 shows 
that only 3 subjects might have a residual effect, because all the other subjects 
(77%) increase/decrease in both legs (7 subjects) or have no change in the 
treatment leg (3 subjects). When the results from 24 hours after KT removal are 
compared to before KT application, 5 of 12 subjects (42%) VM time to minimum 
rSO2 increase/decrease in both legs. 6 of 12 subjects (50%) increase/decrease 
oppositely between the two legs, but 5 subjects have time to minimum rSO2 delayed 
in treatment leg and a shift to an earlier time in the control leg. The paired t-test 
results show that D2 (p=0.332) and D6 (p=0.826) both have no statically significant 


























Table 27: Number of subjects in each category of changes in VM time to minimum rSO2 levels based on the 
residual of KT application results. D7 (the day after 24 hours KT removed) compare to D6 (The last day of test 
with KT application), D2 (A day before KT application wearing) 
Changes in VM time to minimum rSO2 levels from D7 
Number of subjects 
D7-D6 D7-D2 
Increased in both legs 3 3 
Decreased in both legs 4 2 
Treatment leg increased 1 5 





Total subjects 13 12 
* control leg time to minimum rSO2 levels decreased, treatment leg time to minimum rSO2 
levels no change 
** both legs time to minimum rSO2 levels no change 
 
 
Figure 37: Box plot of the treatment leg VM time to minimum rSO2 levels for D2, D6, and D7. ♦ indicates an 
outlier. * indicates statistical significance between mean VM time to minimum rSO2 levels (indicated by horizontal 
line within bar) for D7 compare to D6 and D2 in treatment leg VM muscles 
 
 Vastus Lateralis (VL): Table 28 shows that 8 of the subjects (62%) did not 
increase/decrease simultaneously in two legs after the acute KT application. 
























are decreased. Therefore, two-sided paired t-test was chosen for analysis. The result 
shows no statistically significant difference between D2 and acute KT application 
(p=0.814). 
Table 28: Number of subjects in each category of changes in VM time to minimum rSO2 levels based on acute 
KT application 
Changes in VL minimum rSO2 levels between D3 and D2 Number of subjects 
Increased in both legs 2 
Decreased in both legs 3 
Treatment leg increased 4 
Control leg increased 4 
Total subjects 13 
 
 
Figure 38: Box plot of the treatment leg VL time to minimum rSO2 levels for D2 and D3. ♦ indicates an outlier. * 
indicates statistical significance between mean time to minimum rSO2 levels (indicated by horizontal line within 
bar) for D2 and D3 
 
 VM (Table 26) and VL (Table 29) have almost the same number of subjects in 























application, VM and VL have almost the same number of subjects in the same group 
as well. After 48 hours, for the VL muscle, 11 of 14 subjects (79%) indicate that KT 
will not change the time to minimum rSO2 levels when compared to acute KT 
application and 48 hours of KT application. The duration of KT application results 
from 24 (p=0.063), 48 (p=0.367), and 72 hours (p=0.529) show that the subjects did 
not experienced a statistically significant difference in time to minimum rSO2 levels 
after applying the KT. 
Table 29: Number of subjects in each category of changes in VL time to minimum rSO2 levels for each 24 hours 
period of KT application through D6 (72 hours after KT application) 
Changes in VL time to minimum rSO2 levels from D3 
  
Number of subjects 
D4-D3 D5-D3 D6-D3 
Increased in both legs 4 6 4 
Decreased in both legs 5 5 4 
Treatment leg increased 2 2 4 
Control leg increased 2 0 1 
No change 0 1** 1** 
Total subjects 13 14 14 
* control leg time to minimum rSO2 levels decreased, treatment leg time to minimum rSO2 no 
change 







Figure 39: Box plot of VL time to minimum rSO2 levels for D3, D4, D5, and D6 in treatment leg. ♦ indicates an 
outlier. * indicates statistical significance between mean time to minimum rSO2 levels (indicated by horizontal line 
within bar) for D3 to D4, D5, D6 
 
 After removing the KT for 24 hours, 8 subjects (62%) show that the treatment 
leg increases/decreases differently from the control leg, However, 4 of 8 subjects 
time to minimum rSO2 increased, and the other 4 subjects decreased, which cannot 
demonstrate that KT has a residual effect in time to minimum rSO2 levels. When D7 
is compared to D2, 67% of subjects’ time to minimum rSO2 in both legs changed 
simultaneously (Table 30). Moreover, the paired t-test results (Figure 40) interpret 
that no significant difference were found when comparing D7 to before KT 
application (p=0.626) and after 72 hours of KT application (p=0.201). the residual 
effect from KT does not exist due to the D7 comparison to before KT application and 



























Table 30: Number of subjects’ in each category of changes in VL time to minimum rSO2 levels based on the 
residual of KT application results. D7 (the day after 24 hours KT removed) compare to D6 (The last day of test 
with KT application), D2 (A day before KT application wearing) 
Changes in VM minimum rSO2 levels from D7 
Number of subjects 
D7-D6 D7-D2 
Increased in both legs 1 2 
Decreased in both legs 4 6 
Treatment leg increased 3 2 





Total 13 12 
* treatment leg time to minimum rSO2 levels decreased, control leg time to minimum rSO2 
levels no change 
** treatment leg time to minimum rSO2 levels increased, control leg time to minimum rSO2 
levels no change 
*** control leg time to minimum rSO2 levels decreased, treatment leg time to minimum rSO2 
levels no change 
 
 
Figure 40: Box plot of the treatment leg VL time to minimum rSO2 levels for D2, D6, and D7♦ indicates an outlier. 
* indicates statistical significance between mean VL time to minimum rSO2 levels (indicated by horizontal line 


























  Overall, the results demonstrate the changes and trends from D2 to D7. The 
TTF and rate results indicate that significant change is not due to KT, but from 
another factor. The muscle oxygenation results show that KT can change the rSO2 
level. The reason for this is that the rSO2 level significantly changes only occurred on 
the treatment leg during days with KT application. The changes in muscle 
oxygenation in VL and VM have different influences from KT application. Even 
though the VM muscle has some significant changes from KT in the sitting baseline 
result, VL had larger changes. However, in the minimum rSO2 level comparison, VM 
has significantly smaller rSO2 levels during KT application (D2 to D3), but no obvious 
changes occur in the VL muscle. The implications of these results will be explored in 





Chapter 4 Discussion 
 The aim of this research project was to assess Kinesio Tape application 
effectiveness on isotonic fatiguing knee flexion/extension exercise. The results 
revealed that the application of KT to the knee joint does not enhance the 
performance of the knee in terms of TTF, rate or muscle oxygenation level in healthy 
subjects. Nevertheless, during the eight days of testing some delays in TTF, 
enhancements in rate of flexion/extension, and change in muscle oxygenation were 
observed in both legs – the leg that KT was applied to for 4 days and the control leg.  
4.1 Fatiguing of Isotonic Knee Flexion Extension Exercise 
 4.1.1 Time to Fatigue (TTF): As a part of this research study it was 
hypothesized that KT application would delay the TTF during knee the 
flexion/extension isotonic exercise. Based on the results of the study the hypothesis 
cannot be supported. The reason is that the OR of D3 compared to D2 is equal to 
0.75. The fact that acute KT application will not increase the TTF was supported by 
the Wilcoxon signed ranking test, OR, and the raw data. Secondly, the lack of a KT 
application duration effect on increasing the TTF was supported by the RR from 24 
hours KT application to 72 hours KT application and the statistic results. 
Furthermore, the raw data shows that during the KT application, there are always 
64% to 86% of subjects whose results suggest that KT is not the main factor to 
enhance the TTF. Thirdly, the KT residual effect in TTF was not discovered in this 
study. Even though the treatment leg result on D7 compared to D6 and D2 both 
indicate that the TTF still increases after removal of KT, the control leg results 
provide evidence that the effect is not from KT residual. Overall, the results suggest 




results of effects other than the KT.  
 Unlike the findings of the Knapman et al. (2016) study that showed healthy 
subjects’ enhancement of the maximal extension peak torque in isokinetic exercise 
on lumbar due to KT application, this case-control study findings cannot support that 
the enhancement of the performance of a knee flexion/extension isotonic exercise 
protocol can be attributed to KT. The comparison of the treatment leg to the control 
leg provides important evidence that, based on the current results, the improvements 
could be attributed to a “learning effect” from the exercise performance over multiple 
days, rather than KT application.  Poon (2014), in a review of isokinetic performance 
papers, states that observed changes in performance could be a placebo effect. In 
the TTF data there were no subjects for which the treatment leg TTF increased 
without a corresponding increase in control leg TTF. Therefore, it appears that no 
placebo effect was found in the TTF data when looking at the raw data. Moreover, 
TTF for 5 of 13 subjects increased consistently for both legs every day, which 
indicates a learning effect may have existed (K. Jackson et al., 2016; J.T. Han et al., 
2014; C. Fahs et al., 2015).  
 
 4.1.2 Rate of Flexion/Extension: The results concerning hypothesis 2 show 
that the rate changed over time, but there was no evidence that the increase in rate 
was caused by KT application. The enhancements due to acute KT application were 
shown in the treatment leg in D3 compared to D2 (p=0.027) and OR (1.8), but the 
Power shows only a 66.93% chance that an increase of rate is actually due to the 
acute KT application. Therefore, increasing the number of subjects is needed in a 




in treatment leg was not significantly different from the control leg (p=0.11), which 
suggests that the increase in treatment leg was not due to the acute KT application. 
The duration of KT application was proven to have negative effect after 24, 48, and 
72 hours by RR result, and the Wilcoxon signed raking test also provides that no 
significant increase showed from extending the duration of KT application. The 
residual effect did not exist in the rate results, although the result in D7 compare to 
D2 shows a statistically significant increase. However, the control leg comparison 
and D2 compared to other days both support that the two legs have similar rate 
results, and the rate in both legs show increases. The time series result support the 
statement that the rate increase is caused by learning effect, because the difference 
trends between two legs are statistically insignificant.  
 Time series theory provides additional learning effect evidence. According to 
the number of subjects whose TTF and rate increased by the day factor, it is 
possible that most of the subjects enhanced their performance by practicing. 
However, some of the subjects have a negative coefficient in the time series. This 
result suggests that the relationship between TTF and rate be investigated. All the 
negative coefficients (β) in TTF or rate have a positive coefficient (β) on the opposite 
side (Table A- 5, Table B- 5). As a result, TTF decreases are caused by increasing 
rate (frequency). In contrast, a negative rate coefficient corresponds to a positive 
coefficient in TTF. Nevertheless, learning effect was also defined by the case and 
control leg time series comparison, TTF and rate both show that the treatment leg’s 
performance is similar to the control leg. 
 Subject 12 has a lower TTF time series coefficient, but has the highest rate 
time series’ coefficient in both legs. The questionnaire provides evidence that the 




participated in high intensity sports. From D4 to D7, subject 12 TTF increased 
consistently. On the other hand, 3 of the subjects’ control leg and 4 of the subjects’ 
treatment leg have a negative coefficient (β) in the TTF time series result (Eq 6). 
However, when examining the rate time series, the TTF decrease could be explained 
by subjects increasing the rate after D2. None of the subjects had TTF and rate 
response with negative coefficients at the same time in the time series, which 
indicates that subjects learned to perform better in TTF or rate. 
A previous study mentioned that English soccer players will have different 
muscle strength and flexibility on the dominant and non-dominant legs, which is 
because the training that soccer players undergo are more focused on the dominant 
leg (Rahnama, 2005). Overall, in this study, the TTF and rate results both indicate 
that learning effect is the main cause of performance enhancement.  It is clear that 
for TTF and rate there is no significant change in performance due to KT application 
or after its removal, which goes against some of the KT manufacturers’ claims about 
performance enhancement (Hypothesis 1 & Hypothesis 2). In another point of view, 
the treatment leg and control leg results also provide evidence to show that in 
fatiguing isotonic flexion/extension exercise, the two legs TTF and rate performance 
are similar. A prior project assessed a balance leg training that was able to decrease 
the asymmetry between two legs in young tennis players (I. Sannicandro, 2014). 
Another study assessed that runners have similar performance in stride length (K. 
Maćkała, 2010), ground contact time (P.W. Wong, 2008), unilateral squat strength, 
and weight bearing stance (K. McCuedy, 2005) in both legs. The study shows that 
subjects who are runners or basketball players will have leg symmetry due to 
balanced leg training, which could eliminate the concerns in this study that 50% of 





When looking at the data broadly, the results show that a learning effect is 
present, but also that some subjects improve less after KT application, and some of 
the subjects have more random changes in performance. This section discusses the 
category and classifies method results.  
First, none of the subjects’ TTF and rate decrease at the same time in the 
time series analysis. Secondly, all the negative TTF coefficient values in the time 
series match with a positive coefficient in the rate time series results, and vice versa. 
Therefore, summarizing the result from the questionnaire, raw data, and time series 
analysis, subjects could be classified into three different groups (a) Learning, (b) 
Placebo (González-Iglesias, 2009; Poon, 2014), and (c) rate control. According to 
the TTF and rate result, 5 of the subjects can be classified as learning effect, 
because the raw data increases by days, and the time series coefficients (β) are 
positive in TTF and rate (Table 31). A second group of subjects are classified due to 
the questionnaire results which indicate that those subjects believe that KT 
enhanced their performance. However, when examining the performance data for 
these subjects, (1) only a few subjects enhanced their performance during KT 
application, which means the KT did not actually improve subject performance, and 
(2) some subjects’ performances are randomly varied, or always increasing, even 
after removal of the KT (for instance: S7, S8) (Table 31). Therefore, Subject 7 and 
Subject 8 were classified in both the learning and placebo groups. The third group 
were categorized by checking the TTF and rate result at the same time. 5 of the 
subjects’ performance changed randomly from D2 through D7. However, when the 
TTF decreased, an increasing rate was found in the result, and the endurance and 




but also associated with the rate changing. Nevertheless, the control leg and 
treatment leg show no dramatic difference between one another, which also 
indicates that the TTF performance changed by subjects’ body decreases or 
increases by the rate, not by KT.  
Table 31: Subjects grouped by learning effect, placebo effect, and rate control effect 
Learning Placebo Rate Control 
S3 S1 S5 
S4 S2 S6 
S7 S7 S11 
S8 S8 S12 
S10 S9 S14 
 S13  
 
4.2 Muscle Oxygenation 
 It was hypothesized that the use of KT would change the leg muscle sitting 
baseline rSO2 level (Hypothesis 3), rSO2 minimum levels (Hypothesis 4) and the time 
to minimum rSO2 level (Hypothesis 5). The manufacturers claim that KT will increase 
the blood flow and muscle oxygenation. The results of this research evaluate the 
truth of those claims.  
 4.2.1 Sitting Baseline rSO2 level:  
 The manufacturer explained and believed that the skin was stretched back by 
KT (KT, Rock tape website). Therefore, KT not only increases the blood flow but also 
indirectly increases the muscle oxygenation. 




shows that the muscle oxygenation baseline will not significantly change by 
measuring at different times (Cole, 2011).  
 The results reject hypothesis 3a, the acute KT application did not increase the 
VL or VM sitting baseline. The paired t-test states that the VM difference between D3 
and D2 is not large enough to show the statistical significance (p=0.062), even 
though the sitting baseline in VM raw data grouping shows that the treatment leg 
only has two situations, (a) sitting baseline increase (b) sitting baseline decrease 
with control leg as well, and OR is equal to 6. The control leg results in the VM 
muscle shows that D3 compared to D2 is a statistically insignificant increase 
(p=0.825, mean difference=-1.14), which also gives evidence that the sitting baseline 
might decrease if the treatment leg has no KT application. The follow-up study needs 
to increase the number of subjects to show the truth. 
 The effect of acute KT application in VL sitting baseline has an OR greater 
than 1 (OR=2.133) which indicates that the acute KT application is associated with 
VL sitting baseline increasing. Nevertheless, although the paired t-test shows that VL 
sitting baseline is statistically significantly increased (p=0.045) by the acute KT 
application, it could be a false positive because the Power shows only a 64.2% 
chance that the increase in TTF could be explained by acute KT application. 
Nevertheless, the control leg result can be examined to show if the trends in the two 
legs’ sitting baseline are similar. The result in the control leg VM presents that no 
statistically significant increase was found in sitting baseline (p=0.198). The follow-up 
study needs to include more subjects to show if the increase is truly positive. As a 
result, both VM and VL show that the acute KT application could be associated with 




 Hypothesis 3b was rejected by the VM and VL results. According to the VM 
results, the sitting baseline in some of the subjects decreased more by extending the 
KT application duration. The VM sitting baseline RR and paired t-test results 
explained that a longer duration of KT application will decrease the sitting baseline. 
Two possible reasons could be made, (a) the KT has a decreasing effect in VM 
muscle sitting baseline, (b) KT had an effect in acute KT application, but the 
effectiveness decreased with the duration of KT application. 
 VL and VM have similar results, but the RR in VL is always greater than 1. 
However, when the KT application is extended, less association was seen between 
KT and sitting baseline increases. Moreover, the paired t-test results suggest that the 
duration of KT application is not a factor in increasing the VL sitting baseline. 
 The hypothesis 3c was rejected by the D7 comparisons. The residual effect 
can be defined in two ways, (a) the sitting baseline still increases after KT is 
removed, and (b) the sitting baseline on D7 is close to the value with KT application. 
In both VM and VL the results indicate that D7 did not statistically significantly 
increase in sitting baseline when compare to D6, which suggests that the residual 
effect (a) is invalid. When D7 is compared to D2, both VM and VL results indicate no 
statistically significant increase in sitting baseline after KT removal. As a result, the 
residual definition (b) is abandoned as well, and no residual effect in rSO2 sitting 
baseline was suggested. 
 4.2.2 Minimum rSO2 level:  
 The literature review in this study did not find any previous research that 
discussed the minimum rSO2 variable. Moreover, no reference can be considered to 




test was chosen to investigate the change of minimum rSO2. 
 In the VM muscle, hypothesis 4a failed to reject, due to the minimum rSO2 
levels’ statistically significant change after the acute KT application (p=0.022, 
Power=80.7%). Not only that, to prove that the effect from acute KT application is 
true, the control leg was tested as well. The control leg result on D3 compared to D2 
shows the minimum rSO2 in VM is statistically insignificantly different (p=0.969, 
mean difference=0.0006). The mean difference in the treatment leg is equal to 
0.0663, which determines that the acute KT increases the minimum rSO2 in the VM. 
Moreover, the raw data also suggests that more than 69% of subjects have 
increased the minimum rSO2 levels in the treatment leg VM when comparing D3 to 
D2. The reason for minimum rSO2 increasing could be attributed to the 
manufacturers claim that the blood flow and muscle oxygen will be increased by KT. 
 The VL muscle rejects hypothesis 3a because the difference between D3 and 
D2 is not large enough. According to the raw data, even though 10 subjects 
increased the minimum rSO2 value on D3, the increase in the minimum rSO2 levels 
cannot support that the difference truly exists. 
 Both VM and VL suggest that the duration of KT application will not affect the 
minimum rSO2. The results reject hypothesis 4b, because 24, 48, and 72 hours of 
KT application have no statistically significant changes when compared to D3.  
 Hypothesis 4c was rejected because VM and VL have no evidence to support 
the definition (a) and (b) for residual effects. However, according to the raw data 
grouping, D7 to D6 in the VM shows that 9 subjects’ treatment leg minimum rSO2 
levels decreased (69%). Yet, when D7 is compared to D2, 50% of subjects’ 




other hand, VL minimum rSO2 raw data also shows 9 subjects’ treatment leg 
minimum rSO2 decreased. 8 subjects decreased in D7 compare to the D2 result, and 
it is rational that D7 compared to D6 and D2 have similar results, because no 
statistically significant differences were found in the VL muscle. 
 4.2.3 Time to minimum rSO2 in the trial: 
 Based on the literature review in this study, none of the studies discuss the 
time to minimum rSO2 variable. Also, no trend was found in the raw data, and the 
two-sided paired t-test was chosen to examine the differences. The influence in time 
to minimum rSO2 in the trial is not related to KT. The acute KT application did not 
change the VM and VL time to minimum rSO2 result, based on the D3 to D2 
comparison which has no statistically significant changes. Therefore, hypothesis 5a 
was rejected. Secondly, the results of the duration of KT application in time to 
minimum rSO2 in the VM and VL muscles also show no statistically significant 
change, hence hypothesis 5b was rejected. The duration of KT application results tell 
that after a longer KT application, more subjects will have different changes. 
However, the treatment leg did not provide any evidence that KT will delay the time 
to minimum rSO2 or shift to an earlier time. Just as for the other hypothesis results, 
the residual effect was not found after KT was removed for 24 hours. 
 The reason for no change in time to minimum muscle oxygenation could be 
due to the fact that the time is related to the subject’s isotonic exercise performance, 
and every subject utilized the muscles to execute the task in a different way. First of 
all, according to the TTF results, both legs’ TTF are enhanced, but the calculation of 
time to minimum rSO2 level in the trial is based on TTF and the time that minimum 




similar but TTF increased, the minimum rSO2 time is postponed actually. As a result, 
the muscle oxygenation uptake duration and recovery start point are related to the 
exercise duration, and not necessarily independent. 
 Overall, every subject consumes the rSO2 in the VM and VL muscle 
differently. Surprisingly, some of the subjects consume the rSO2 differently between 
the control leg and treatment leg. But according to the 14 subjects’ muscle 
oxygenation results, 3 main categories can be defined as below: 
1. Some subjects will see a recovery during the isotonic 
flexion/extension exercise when it reaches to the minimum rSO2. 
The VL muscle in some of the subjects has more oxygen uptake 
than the VM muscle during the isotonic flexion/extension exercise, 
and it also recovers more from the minimum rSO2 levels (Figure 
34). 
2. The VL and VM muscles in some of the subjects will have the same 
trend which consumes and recovers the rSO2 simultaneously during 
the trial (Figure 41). 
3. Some of subjects always decrease until the end of the trial (Figure 






Figure 41: rSO2 levels - D4 Subject 9 control Leg - an example of when VL and VM have similar rSO2 
consumption and trends. The time displayed in the graph is the respective end of that trial 
 
Figure 42: rSO2 levels - D4 Subject 12 treatment Leg - An example of when VM and VL rSO2 levels decrease 
until the end of the trial. The time displayed in the graph is the respective end of that trial 
4.3 Summary 
  The goal of this research was to quantify the changes in performance 

















































no evidence found to support that KT enhances isotonic knee flexion/extension 
endurance performance. The results of the subjects from acute and prolonged KT 
application were distributed from increasing, no change, and decreasing in TTF and 
rate.  Subjects who were observed to have increased their performance also had 
indications of a learning effect or placebo effect.   
 There were changes due to KT application among the muscle oxygenation 
variables.  The minimum level of rSO2 during exercise did increase due to acute KT 
application.  This could be due to the tape stretching the skin away from the muscle 
allowing oxygenated blood to flow more readily (which is claimed by the 
manufacturer), and thus the rSO2 level did not reduce as much. Besides the increase 
observed in minimum rSO2, KT did not result in any performance or muscle 
oxygenation changes.  
4.4 Study Limitations 
 There are several limitations to this study that should be acknowledged. First, 
the duration of the test is eight days, which may not be long enough if evaluating the 
effect of KT on injury recovery. Future studies can have a longer project schedule to 
get more subjects enrolled. 
 Secondly, muscle strength could be included as a factor in future studies. 
There is substantial literature that uses electromyography to evaluate muscle 
strength and discuss the difference with/without Kinesiology Tape (Y. Konishi, 2013; 
Y. Shah, 2017; W. Moalla, 2006; C.Y. Huang, 2011; K. MacGregor, 2005; J. H. van 
Diee¨n, 2007). However, no study examined muscle strength (EMG data) with 
isotonic exercise. The performance changes from using KT might be more clearly 





 Third, the KT was always put on subjects’ dominant leg in this research, which 
blocked the KT influences on the dominant and non-dominant leg. Future studies 
could add the leg factor to the experiment. Additionally, only one brand and one type 
of KT was used in this study, which limits the generalization of the results to all KT. 
 And last but not the least, the NIRS sensors are all put on the quads in this 
research. However, if the future study could overcome the comfort issue which is 
affected by the sensor placement, leg and Biodex, assessing the hamstring muscles 





Chapter 5 Conclusion 
 This study was the first of its kind to determine the effects of KT application on 
healthy subjects during a fatiguing isotonic knee flexion/extension exercise. The 
reason for this study was to evaluate the claims of performance enhancement.  
Performance variables off TTF and rate were evaluated along with muscle 
oxygenation of the VL and VM muscles. The results in this study were: 
• Application of KT to the knee joint did not enhance TTF and rate 
performance in isotonic flexion/extension exercise.  
•  KT application did increase the VL sitting baseline. 
• Acute application of the KT increase the VM minimum rSO2 levels during 
exercise. 
•  Wearing KT increases the minimum rSO2 levels during exercise. 
 This study did demonstrate that KT can cause changes in an individual 
muscle oxygenation levels through increasing their sitting baseline, and minimum 
level during exercise.  Manufacturers make broad claims that KT can cause this 
changes, and this study supports this claim.  However, manufacturers and athletes 
use this claim to support the notion that KT can also improve performance.  No 
evidence was found in this study to support the notion of enhancing endurance 
performance during an isotonic knee flexion/extension exercise for this particular 
tape.  Any increases could be due to a placebo effect or, also found in the current 
study, a learning effect. Further research should be completed in order to generalize 
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Appendix A: Isotonic Flexion/Extension Exercise TTF 
 
Table A- 1: TTF during isotonic knee flexion/extension exercise from Day 2 to Day 8 
TTF (sec) 
  
Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 
Left Right Left Right Left Right Left Right Left Right Left Right Left Right 
S1 82 93 78 79 86 92 111 118 131 116 122 155 95 89 
S2 39 39 40 39 36 41 48 46 45 49 45 49 51 62 
S3 95.5 103 126 167 105.5 159 139 188 108 218 116.5 234.5 133 244 
S4 114 181 135 217 107 270 144 182 191 211 209 316 258 255 
S5 63 65 70 71 97 92 72 79 91 82 75 79 88 92 
S6 160 70 93 94 75 70 81 91 92 123 N/A N/A N/A N/A 
S7 292 293 286 282 297 324 369 375 387 441 475 467 390 420 
S8 46 45 49 51 58 56 60 59 64 65 67 66 75 72 
S9 36 42 41 45 48 51 52 59 52 44 47 49 51 49 
S10 23 25 11 26 28 21 32 31 28 17 30 30 30 23 
S11 34 35 35 33 40 40 42 32 32 30 37 35 43 35 
S12 47 50 37 48 25 19 19 20 24 23 21 23 22 27 
S13 52 53 58 43 58 57 61 57 60 57 68 86 83 74 





Table A- 2: The distribution of changes in TTF for the treatment and control leg, which was used to calculate the 
OR based on the acute of KT application 
  Treatment Leg Control Leg 
Exposure 
Increase TTF 7 8 
No increase TTF 7 6 
  OR 0.75 
 
Table A- 3: Number of subjects with RR for TTF based on duration of KT application (D3 compare to D4 through 
D6) 
  D4-D3 D5-D3 D6-D3 














9 5 9 5 8 6 
Control Leg 7 7 11 3 9 5 
  RR 1.286 RR 0.818 RR 0.89 
 
Table A- 4: The statistic results for hypothesis 1 a (the acute KT application), 1b (duration of KT application), 1c 









H1a. Acute of KT application D3-D2 -2 20 0.265 33.6% 
H1b. Duration of KT 
application 
D4-D3 5.5 82 0.235 20.5% 
D5-D3 7.5 40 0.063 53.0% 
D6-D3 10 80 0.139 29.4% 
H1c. KT application residual 
effect 
D7-D2 12 162 0.034* 99.6%▲ 
D7-D6 8.5 42 0.005* 92.5%▲ 
H1c. D7 compare to D2 and 
D6 control leg results 
D7-D2 12 37 0.005* 100.0%▲ 
D7-D6 1 34 0.380 38.0% 
* indicates statistical significance between median TTF for each hypothesis comparison  









Table A- 5: The coefficient β in time series shows the TTF trends from D2 to D8 for each subject and each leg.  
Subjects  Control Leg Treatment Leg 
S1 6.14 5.86 
S2 1.964 3.464 
S3 3.43 22.04 
S4 23.71 12.89 
S5 2.82 3.11 
S6 -14.8 10.3 
S7 27.21 31 
S8 4.607 4.286 
S9 2.179 0.79 
S10 2.11 -0.07 
S11 0.821 -0.214 
S12 -3.86 -4.11 
S13 4.107 5.32 
S14 -3.071 -3.46 
Mean Difference 2.42 
SD 8.94 
p-value 0.165 









Appendix B: Isotonic Flexion/Extension Exercise Rate 
 
Table B- 1: Rate during isotonic knee flexion/extension exercise from Day 2 to Day 8 
Rate (cycle/sec) 
  
Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 
Left Right Left Right Left Right Left Right Left Right Left Right Left Right 
S1 0.476 0.505 0.551 0.544 0.500 0.533 0.495 0.517 0.519 0.517 0.541 0.529 0.579 0.663 
S2 0.974 0.974 1.000 0.974 0.972 0.951 0.979 1.000 0.956 0.959 0.956 0.959 0.941 0.935 
S3 0.775 0.835 0.651 0.856 0.853 0.890 0.820 0.872 0.833 0.856 0.850 0.896 0.812 0.881 
S4 0.807 1.061 0.759 0.742 0.822 0.781 0.813 0.753 0.835 0.777 0.787 0.802 0.773 0.694 
S5 0.857 0.792 0.807 0.845 0.825 0.772 0.826 0.810 0.835 0.817 0.840 0.861 0.847 0.793 
S6 0.581 0.700 0.618 0.633 0.633 0.671 0.623 0.610 0.582 0.598 N/A N/A N/A N/A 
S7 0.808 0.812 0.839 0.819 0.862 0.840 0.846 0.891 0.881 0.862 0.851 0.925 0.892 0.886 
S8 0.804 0.800 0.857 0.843 0.845 0.839 0.867 0.915 0.844 0.877 0.896 0.864 0.867 0.875 
S9 0.833 0.762 0.780 0.733 0.833 0.745 0.788 0.695 0.769 0.818 0.894 0.816 0.941 0.939 
S10 0.870 0.800 0.636 0.885 0.786 0.952 0.813 0.968 0.893 1.000 0.833 1.000 0.967 1.087 
S11 0.941 0.800 0.943 0.879 0.925 0.875 0.905 0.938 1.125 0.967 0.919 0.914 0.907 0.914 
S12 0.957 0.960 1.000 0.958 1.000 1.211 1.211 1.300 1.208 1.261 1.238 1.174 1.182 1.185 
S13 0.865 0.981 0.828 1.047 0.879 0.965 0.902 0.982 0.867 0.947 0.912 0.884 0.843 0.892 





Table B- 2: The distribution of changes in rate for the treatment and control leg which was used to calculate the 
OR based on the acute of KT application 
  Treatment Leg Control Leg 
Exposure 
Increase 9 7 
Not increase 5 7 
 OR 1.8 
 
Table B- 3: Number of subjects with RR for rate based on duration of KT application (D3 compare to D4 through 
D6) 
















7 7 9 5 8 6 
Control Leg 8 6 11 3 9 5 
  RR 0.875 RR 0.818 RR 0.89 
 
Table B- 4: The statistic results for hypothesis 2a (the acute KT application), 2b (duration of KT application), 2c 
(KT application residual effect).  








H2a. Acute of KT application D3-D2 0.039 0.239 0.027* 66.9% 
H2a. D3-D2 control leg 
results 
D3-D2 0.034 0.091 0.110 37.5% 
H2b. Duration of KT 
application 
D4-D3 -0.004 0.149 0.556 7.3% 
D5-D3 0.021 0.406 0.094 39.2% 
D6-D3 0.007 0.215 0.201 22.9% 
H2c. Residual after KT 
application 
D7-D2 0.064 0.311 0.015* 88.0%▲ 
D7-D6 0 0.160 0.447 7.6% 
H2c. D7 compare to D2 and 
D6 control leg results 
D7-D2 0.044 0.127 0.033* 63.4% 
D7-D6 0.016 0.184 0.270 24.5% 
* indicates statistical significance between median rate for each hypothesis comparison 








Table B- 5: The coefficient β in time series shows the rate trends from D2 to D8 for each subject and each leg.  
Subjects  Control Leg Treatment Leg 
S1 0.011 0.015 
S2 -0.007 -0.005 
S3 0.018 0.007 
S4 -0.001 -0.035 
S5 0.002 0.003 
S6 0.001 -0.023 
S7 0.011 0.016 
S8 0.009 0.011 
S9 0.017 0.028 
S10 0.028 0.041 
S11 0.002 0.018 
S12 0.049 0.041 
S13 0.003 -0.022 
S14 0.022 0.030 
Mean Difference -0.003 
SD 0.015 
p-value 0.741 




Appendix C: Sitting Baseline in VM/VL Muscles rSO2 Levels Before 
the Test 
Table C- 1: The sitting Baseline rSO2 levels for the. (a) control leg VM muscles (b) control leg VL muscles (c) 
treatment leg VM muscles (d) treatment leg VL muscles 
(a) 
Raw data of sitting baseline % rSO2 levels in control leg VM (%) 
VM D1 D2 D3 D4 D5 D6 D7 D8 
S1 58.00% 68.00% 65.33% 64.00% 69.00% 65.00% 67.00% 81.00% 
S2 61.00% 51.33% 56.67% 57.33% 53.50% 59.00% 58.33% 55.33% 
S3 77.00% 71.00% 66.00% 66.00% 68.00% 72.33% 68.00% 67.00% 
S4 66.00% 70.00% 67.00% 65.50% 66.00% 64.00% 62.00% 69.67% 
S5 47.00% 63.00% 58.67% 57.67% 61.00% 60.00% 64.00% 61.00% 
S6 65.00% 64.00% 66.00% 54.00% 55.33% 60.33% N/A N/A 
S7 63.00% 66.00% 62.33% 63.00% 63.33% 63.00% 63.33% 66.00% 
S8 62.67% 61.50% 62.00% 60.33% 60.00% 55.00% 56.00% 57.00% 
S9 51.33% 56.00% 60.00% 60.00% 54.67% 63.67% 57.00% 57.33% 
S10 39.00% 35.00% 31.33% 44.00% 45.00% 36.67% 36.33% 21.33% 
S11 60.00% 66.00% 65.00% 66.00% 67.00% 66.00% 61.00% 65.00% 
S12 57.67% 56.50% 50.00% 60.00% 53.00% 50.67% 58.00% 52.00% 
S13 59.67% 56.50% 62.00% 65.67% 66.33% 67.33% 59.50% 64.67% 




Raw data of sitting baseline % rSO2 levels in VL control leg (%) 
  D1 D2 D3 D4 D5 D6 D7 D8 
S1 64.00% 67.33% 67.00% 65.00% 63.50% 67.50% 70.00% 83.33% 
S2 64.33% 55.33% 62.00% 62.00% 57.50% 59.67% 59.67% 61.33% 
S3 73.50% 66.00% 65.00% 64.00% 68.67% 72.33% 69.00% 71.00% 
S4 71.50% 71.00% 70.00% 70.00% 71.00% 70.67% 67.67% 71.67% 
S5 44.00% 67.67% 62.00% 58.33% 57.33% 62.50% 64.00% 60.67% 
S6 62.50% 63.00% 66.33% 63.50% 56.33% 63.33% N/A N/A  
S7 70.33% 68.00% 70.67% 66.00% 69.33% 67.00% 68.00% 71.00% 
S8 65.00% 61.00% 64.67% 63.33% 65.00% 59.33% 63.67% 59.00% 
S9 57.00% 57.00% 63.67% 60.67% 57.00% 62.00% 56.00% 57.00% 
S10 55.33% 52.00% 49.67% 58.00% 58.00% 51.00% 52.00% 48.00% 
S11 65.67% 67.00% 67.00% 72.00% 68.75% 69.50% 62.67% 69.00% 
S12 56.67% 54.00% 50.67% 57.00% 56.33% 50.67% 57.50% 45.00% 
S13 65.33% 62.00% 67.00% 69.00% 69.67% 67.00% 66.50% 66.67% 







Raw data of sitting baseline % rSO2 levels in VM treatment leg (%) 
VM D1 D2 D3 D4 D5 D6 D7 D8 
S1 59.00% 63.33% 61.00% 63.00% 56.67% 59.00% 63.50% 74.00% 
S2 59.33% 50.50% 57.00% 59.00% 62.67% 61.00% 61.33% 60.50% 
S3 78.00% 73.33% 80.00% 78.67% 69.00% 77.67% 70.00% 73.00% 
S4 66.33% 64.00% 66.00% 61.00% 63.00% 72.00% 70.00% 68.00% 
S5 53.67% 63.00% 63.67% 70.00% 73.00% 63.00% 64.33% 70.00% 
S6 61.67% 62.50% 66.00% 62.00% 59.33% 65.33% N/A N/A 
S7 61.00% 57.00% 64.00% 53.00% 62.00% 61.00% 65.00% 58.33% 
S8 64.00% 63.00% 66.00% 66.33% 62.00% 61.00% 61.00% 68.00% 
S9 50.67% 61.00% 63.33% 58.00% 56.00% 57.00% 59.00% 58.00% 
S10 52.00% 45.33% 45.67% 46.00% 48.67% 47.33% 43.00% 50.00% 
S11 57.67% 64.00% 64.00% 56.00% 57.00% 62.00% 57.67% 63.00% 
S12 59.67% 59.33% 55.67% 61.00% 51.33% 56.00% 44.67% 47.67% 
S13 60.00% 60.00% 73.00% 68.00% 79.50% 73.00% 58.33% 68.00% 




Raw data of sitting baseline % rSO2 levels in VL treatment leg (%) 
  D1 D2 D3 D4 D5 D6 D7 D8 
S1 64.67% 67.00% 65.00% 65.50% 65.00% 60.33% 67.50% 81.50% 
S2 55.67% 49.50% 51.67% 55.00% 59.33% 57.67% 58.00% 55.50% 
S3 74.00% 71.33% 72.33% 74.67% 68.00% 75.67% 73.00% 69.67% 
S4 70.33% 65.33% 66.00% 68.00% 69.00% 74.00% 69.67% 71.33% 
S5 59.33% 53.00% 62.33% 63.00% 62.67% 57.50% 54.67% 61.00% 
S6 58.33% 58.00% 61.00% 66.00% 56.00% 62.00% N/A N/A 
S7 70.00% 63.00% 66.67% 58.67% 68.67% 67.00% 68.00% 63.33% 
S8 66.33% 66.00% 66.00% 65.33% 67.00% 64.00% 65.50% 69.67% 
S9 54.67% 57.00% 61.00% 57.67% 56.00% 59.00% 56.33% 59.33% 
S10 55.67% 52.00% 51.00% 53.50% 55.00% 55.33% 56.67% 60.33% 
S11 65.67% 69.00% 67.00% 70.00% 68.00% 67.00% 63.67% 67.00% 
S12 56.33% 53.33% 53.00% 59.00% 54.00% 54.00% 48.00% 52.67% 
S13 67.33% 64.00% 67.00% 64.67% 72.00% 69.00% 65.33% 68.00% 








Table C- 2: The distribution of changes in muscle oxygenation sitting baseline for the treatment and control leg 
which was used to calculate the OR based on the acute of KT application. (a) VM muscles. (b) VL muscles 
(a) VM muscles  Treatment Leg Control Leg 
Exposure Outcome 
Increase 10 5 
Not increase 3 9 
  OR 6 
 
(b) VL muscles  Treatment Leg Control Leg 
Exposure Outcome 
Increase 8 6 
Not increase 5 8 
  OR 2.133 
 
Table C- 3: Number of subjects with RR for muscle oxygenation sitting based on duration of KT application (D3 
compare to D4 through D6). (a) VM muscles (b) VL muscles 
(a) VM muscles  D4-D3 D5-D3 D6-D3 









Treatment Leg 6 8 3 11 4 10 
Control Leg 7 7 9 5 10 4 
  RR 0.857 RR 0.333 RR 0.4 
 
 (b) VL muscles  D4-D3 D5-D3 D6-D3 









Treatment Leg 9 5 9 5 8 6 
Control Leg 5 9 7 7 7 7 









Table C- 4: The statistic results for hypothesis 3a (the acute KT application), 3b (duration of KT application), 3c 
(KT application residual effect). (a) VM muscles. (b) VL muscles  









H3a. Acute of KT application D3-D2 2.55 4.75 0.062 60.2% 
H3b. Duration of KT 
application 
D4-D3 -1.94 5.32 0.884 36.3% 
D5-D3 -3.61 3.73 0.993 96.3%▲ 
D6-D3 -0.97 3.56 0.806 24.9% 
H3c. Residual after KT 
application 
D7-D2 0.44 4.65 0.399 10.0% 
D7-D6 0.648 2.764 0.251 20.8% 
* indicates statistical significance between mean muscle oxygenation sitting baseline for each 
hypothesis comparison 
▲ presents the Power is greater than 80% 
 









H3a. Acute of KT application D3-D2 1.849 3.264 0.045* 0.642 
H3b. Duration of KT 
application 
D4-D3 -0.46 4.98 0.622 0.094 
D5-D3 -0.66 3.72 0.724 0.155 
D6-D3 -0.29 3.88 0.600 0.084 
H3c. Residual after KT 
application 
D7-D2 1.32 4.07 0.143 0.311 
D7-D6 -0.78 3.72 0.768 0.184 
* indicates statistical significance between mean muscle oxygenation sitting baseline for each 
hypothesis comparison 






Appendix D: Minimum rSO2 Levels in VM/VL Muscle During the 
Task 
Table D- 1: The minimum rSO2 levels in the trial for the (a) control leg VM muscles (b) control leg VL muscles (c) 
treatment leg VM muscles (d) treatment leg VL muscles 
(a) 
Minimum rSO2 levels in treatment leg VM during the task (% change with sitting baseline) 
 D2 D3 D4 D5 D6 D7 D8 
S1 52.38% 51.52% 31.75% 33.87% 38.81% 36.92% 35.90% 
S2 60.78% 80.36% 88.33% 79.31% 80.95% 68.25% 57.89% 
S3 81.58% 80.25% 78.67% 77.14% 79.49% 83.82% 78.95% 
S4 62.69% 72.86% 83.05% 84.13% 82.35% 61.84% 67.69% 
S5 73.33% 85.48% 85.71% 87.67% 90.77% 80.00% 76.39% 
S6 88.89% 96.77% 90.57% 96.23% 95.08% N/A N/A 
S7 70.49% 86.15% 83.05% 87.50% 77.05% 84.51% 89.23% 
S8 81.36% 90.77% 92.54% 93.22% 86.21% 81.25% 89.23% 
S9 76.47% 83.58% 79.03% 85.71% 85.71% 77.05% 81.67% 
S10 97.92% 90.20% 94.12% 90.38% 97.30% 88.24% 93.88% 
S11 89.06% 89.23% 93.10% 89.06% 89.23% 90.00% 89.06% 
S12 40.91% 50.79% 26.98% 25.37% 33.90% 31.15% 27.59% 
S13 77.59% 77.46% 73.53% 77.92% 78.57% 77.42% 76.47% 
S14 N/A 67.61% 76.56% 58.82% 64.06% 75.00% 70.97% 
 
(b) 
Minimum rSO2 levels in treatment leg VL during the task (% change with sitting baseline) 
  D2 D3 D4 D5 D6 D7 D8 
S1 50.00% 51.52% 34.85% 38.81% 44.78% 39.06% 41.46% 
S2 51.85% 41.38% 46.30% 40.74% 63.79% 50.85% 58.18% 
S3 46.97% 56.25% 53.85% 58.44% 56.58% 43.48% 50.65% 
S4 33.82% 36.59% 19.70% 32.84% 40.54% 39.51% 34.33% 
S5 9.59% 25.37% 32.89% 27.14% 43.28% 25.68% 50.00% 
S6 53.23% 59.70% 52.31% 56.45% 65.15% N/A N/A 
S7 32.86% 31.43% 23.44% 35.71% 31.34% 55.07% 58.33% 
S8 49.28% 64.18% 62.86% 55.07% 59.09% 46.97% 43.28% 
S9 55.71% 59.72% 55.07% 60.34% 51.61% 55.74% 57.97% 
S10 92.59% 96.30% 89.47% 94.44% 91.67% 89.83% 89.83% 
S11 33.80% 50.00% 42.86% 42.31% 45.07% 32.31% 25.40% 
S12 6.45% 12.90% 7.35% 4.35% 20.34% 0.00% 1.72% 
S13 77.94% 61.76% 67.16% 70.83% 69.01% 67.61% 75.71% 







Minimum rSO2 levels in control leg VM during the task (% change with sitting baseline) 
  D2 D3 D4 D5 D6 D7 D8 
S1 50.00% 46.38% 52.17% 57.35% 52.17% 52.94% 51.25% 
S2 62.00% 60.71% 56.14% 49.06% 68.52% 53.45% 39.13% 
S3 84.93% 78.38% 85.07% 80.30% 85.48% 80.26% 81.33% 
S4 64.29% 67.14% N/A 55.22% 65.15% 65.57% 63.77% 
S5 68.75% 69.70% 72.73% 70.59% 73.44% 79.03% 76.12% 
S6 80.33% 83.33% 80.00% 82.54% 84.62% N/A N/A 
S7 67.69% 74.63% 69.84% 75.36% 79.37% 73.53% 94.03% 
S8 95.16% 93.75% 90.16% 88.52% 90.38% 87.93% 92.98% 
S9 83.33% 88.52% 85.71% 87.27% 85.48% 86.67% 91.53% 
S10 97.56% 100.00% 100.00% 97.83% 97.50% 97.67% 100.00% 
S11 76.12% 80.88% 81.54% 75.36% 76.06% 80.33% 79.10% 
S12 48.39% 24.56% 51.61% 21.74% 50.88% 41.38% 24.14% 
S13 83.33% 82.46% 79.10% 77.61% 82.09% 79.31% 78.57% 




Minimum rSO2 levels in control leg VL during the task (% change with sitting baseline) 
  D2 D3 D4 D5 D6 D7 D8 
S1 13.85% 33.33% 50.70% 20.97% 40.30% 40.91% 38.75% 
S2 61.02% 60.00% 70.97% 63.16% 72.13% 70.49% 57.14% 
S3 59.15% 43.42% 42.42% 63.77% 48.57% 36.71% 53.16% 
S4 28.95% 46.75% N/A 41.03% 44.59% 38.24% 38.67% 
S5 36.92% 21.13% 32.84% 28.36% 33.33% 40.58% 35.82% 
S6 36.21% 46.03% 22.58% 31.75% 50.00% N/A N/A 
S7 64.79% 72.97% 48.48% 57.33% 55.56% 64.29% 86.30% 
S8 33.82% 52.17% 38.81% 57.58% 63.79% 62.50% 26.79% 
S9 77.78% 79.37% 75.76% 75.00% 83.33% 84.21% 84.48% 
S10 91.23% 98.11% 93.10% 91.38% 96.08% 96.23% 96.08% 
S11 34.78% 44.29% 40.54% 32.47% 33.77% 44.44% 13.89% 
S12 15.63% 3.57% 14.75% 8.62% 5.66% 25.00% 1.89% 
S13 88.14% 81.82% 87.14% 80.28% 85.07% 85.07% 81.54% 










Table D- 2: The statistic results for hypothesis 4a (the acute KT application), b (duration of KT application), c (KT 
application residual effect). (a) VM muscles. (b) VL muscles  









H4a. Acute of KT application D3-D2 0.066 0.081 0.022* 80.7%▲ 
H4a. D3-D2 control leg 
results 
D3-D2 0.001 0.051 0.967 5.4% 
H4b. Duration of KT 
application 
D4-D3 0.015 0.056 0.384 14.9% 
D5-D3 0.014 0.037 0.241 25.7% 
D6-D3 0.005 0.052 0.741 06.3% 
H4c. Residual after KT 
application 
D7-D2 0.021 0.063 0.314 21.5% 
D7-D6 -0.040 0.095 0.189 31.4% 
* indicates statistical significance between mean minimum rSO2 levels in the trial for each hypothesis 
comparison 
▲ presents the Power is greater than 80% 









H4a. Acute of KT application D3-D2 0.041 0.100 0.182 42.6% 
H4b. Duration of KT 
application 
D4-D3 -0.028 0.097 0.297 17.2% 
D5-D3 -0.016 0.064 0.379 13.5% 
D6-D3 0.020 0.094 0.321 16.9% 
H4c. Residual after KT 
application 
D7-D2 0.007 0.103 0.820 5.7% 
D7-D6 -0.063 0.125 0.125 41.7% 
* indicates statistical significance between mean minimum rSO2 levels in the trial for each hypothesis 
comparison 








Appendix E: Time to Minimum rSO2 Levels During the Trial 
Table E- 1: The minimum rSO2 levels’ in the trial for the (a) control leg VM muscles (b) control leg VL muscles (c) 
treatment leg VM muscles (d) treatment leg VL muscles 
(a) 
Time to minimum rSO2 levels in control leg VM (% of TTF) 
  D2 D3 D4 D5 D6 D7 D8C 
S1 95.46% 86.36% 37.93% 55.17% 51.43% 60.61% 29.03% 
S2 63.64% 58.33% 63.64% 46.67% 50.00% 61.54% 40.00% 
S3 23.08% 15.15% 21.43% 81.08% 21.43% 19.35% 17.14% 
S4 23.33% 17.14% N/A 18.92% 12.24% 11.32% 10.45% 
S5 29.41% 38.89% 24.00% 52.63% 33.33% 95.00% 33.33% 
S6 15.00% 32.00% 40.00% 50.00% 68.00% N/A N/A 
S7 34.21% 60.27% 49.33% 40.86% 39.80% 52.50% 6.06% 
S8 38.46% 42.86% 37.50% 35.29% 29.41% 27.78% 25.00% 
S9 70.00% 58.33% 50.00% 42.86% 53.33% 38.46% 50.00% 
S10 57.14% 25.00% 12.50% 66.67% 100.00% 55.56% 11.11% 
S11 60.00% 90.00% 58.33% 50.00% 54.55% 81.82% 50.00% 
S12 53.85% 54.55% 100.00% 83.33% 100.00% 100.00% 85.71% 
S13 60.00% 100.00% 93.33% 94.12% 64.71% 50.00% 68.18% 
S14 37.50% 35.71% 40.00% 38.46% 58.33% 40.00% 30.77% 
 
(b) 
Time to minimum rSO2 levels in control leg VL (% of TTF) 
  D2 D3 D4 D5 D6 D7 D8C 
S1 100.00% 86.36% 41.38% 58.62% 28.57% 69.70% 25.81% 
S2 100.00% 58.33% 100.00% 53.33% 58.33% 53.85% 53.33% 
S3 23.08% 18.18% 35.71% 13.51% 21.43% 19.35% 17.14% 
S4 23.33% 14.29% N/A 18.92% 12.24% 11.32% 10.45% 
S5 35.29% 38.89% 24.00% 52.63% 33.33% 50.00% 33.33% 
S6 20.00% 28.00% 40.00% 31.82% 36.00% N/A N/A 
S7 10.53% 16.44% 68.00% 81.72% 51.02% 48.33% 13.13% 
S8 46.15% 50.00% 37.50% 41.18% 29.41% 27.78% 25.00% 
S9 70.00% 58.33% 42.86% 50.00% 53.33% 38.46% 42.86% 
S10 71.43% 100.00% 62.50% 66.67% 37.50% 66.67% 33.33% 
S11 60.00% 60.00% 50.00% 50.00% 54.55% 54.55% 41.67% 
S12 53.85% 54.55% 87.50% 83.33% 85.71% 85.71% 100.00% 
S13 40.00% 37.50% 33.33% 35.29% 35.29% 33.33% 31.82% 







Time to minimum rSO2 levels in treatment leg VM (% of TTF) 
  D2 D3 D4 D5 D6 D7 D8T 
S1 44.000% 100.00% 90.00% 28.13% 83.33% 90.00% 96.15% 
S2 63.636% 54.55% 50.00% 42.86% 46.15% 46.67% 29.41% 
S3 77.778% 86.05% 90.24% 82.00% 96.43% 86.67% 91.94% 
S4 13.043% 16.36% 14.49% 14.89% 14.81% 88.75% 9.23% 
S5 38.889% 47.37% 25.00% 28.57% 22.73% 42.86% 58.33% 
S6 26.316% 24.00% 36.84% 32.00% 15.15% N/A N/A 
S7 69.333% 27.78% 47.56% 38.95% 50.89% 37.29% 26.42% 
S8 38.462% 35.71% 31.25% 31.25% 100.00% 100.00% 100.00% 
S9 50.000% 50.00% 42.86% 37.50% 50.00% 50.00% 46.15% 
S10 71.429% 100.00% 85.71% 77.78% 100.00% 77.78% 71.43% 
S11 40.000% 44.44% 45.45% 55.56% 55.56% 50.00% 50.00% 
S12 92.857% 78.57% 100.00% 100.00% 100.00% 100.00% 75.00% 
S13 80.000% 83.33% 93.75% 81.25% 93.75% 34.78% 100.00% 
S14 N/A 20.00% 41.67% 30.77% 36.36% 21.43% 21.43% 
 
(d) 
Time to minimum rSO2 levels in treatment leg VL (% of TTF) 
  D2 D3 D4 D5 D6 D7 D8T 
S1 32.00% 100.00% 53.33% 28.13% 36.67% 30.00% 61.54% 
S2 63.64% 100.00% 100.00% 100.00% 69.23% 100.00% 58.82% 
S3 25.93% 13.95% 14.63% 14.00% 98.21% 10.00% 91.94% 
S4 13.04% 10.91% 8.70% 12.77% 12.96% 7.50% 10.77% 
S5 38.89% 31.58% 50.00% 38.10% 36.36% 66.67% 29.17% 
S6 31.58% 28.00% 36.84% 32.00% 24.24% N/A N/A 
S7 81.33% 43.06% 32.93% 88.42% 52.68% 24.58% 15.09% 
S8 38.46% 57.14% 37.50% 37.50% 27.78% 33.33% 30.00% 
S9 58.33% 66.67% 50.00% 43.75% 58.33% 50.00% 46.15% 
S10 85.71% 71.43% 85.71% 55.56% 100.00% 55.56% 71.43% 
S11 60.00% 77.78% 72.73% 66.67% 66.67% 70.00% 60.00% 
S12 50.00% 64.29% 100.00% 85.71% 100.00% 57.14% 62.50% 
S13 100.00% 41.67% 37.50% 43.75% 87.50% 100.00% 40.00% 








Table E- 2: The statistic results for hypothesis 5a (the acute KT application), 5b (duration of KT application), 5c 
(KT application residual effect). (a) VM muscles. (b) VL muscles  









H5a. Acute of KT application D3-D2 0.033 0.224 0.609 8.0% 
H5b. Duration of KT 
application 
D4-D3 0.019 0.138 0.613 7.7% 
D5-D3 -0.062 0.227 0.326 15.7% 
D6-D3 0.069 0.217 0.253 19.9% 
H5c. Residual after KT 
application 
D7-D2 0.104 0.356 0.332 17.4% 
D7-D6 -0.018 0.294 0.826 5.5% 
* indicates statistical significance between mean time to minimum rSO2 levels in the trial for each 
hypothesis comparison 
▲ presents the Power is greater than 80% 









H5a. Acute of KT application D3-D2 0.021 0.318 0.814 5.6% 
H5b. Duration of KT 
application 
D4-D3 -0.017 0.193 0.753 6.0% 
D5-D3 -0.037 0.262 0.607 7.8% 
D6-D3 0.063 0.367 0.529 9.2% 
H5c. Residual after KT 
application 
D7-D2 -0.036 0.245 0.626 7.9% 
D7-D6 -0.123 0.329 0.201 25.6% 
* indicates statistical significance between mean time to minimum rSO2 levels in the trial for each 
hypothesis comparison 














Figure F- 1: The rSO2 levels in control leg VM and VL during isotonic exercise from D2 to D8 in Subject 1. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 2: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 1. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 3: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 2. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed in 
the graph is the respective end of that trial 
0
100
























































































































Figure F- 4: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 2. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 5: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 3. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed in 











































































































































































Figure F- 6: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 3. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 7: The rSO2 levels control leg VM and VL during isotonic exercise (no D4 data) in Subject 4. (a) D2 (b) D3 (c) D5 (d) D6 (e) D7 (f) D8. The time displayed in the graph 
is the respective end of that trial 
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Figure F- 8: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 4. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 9: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 5. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed in 
the graph is the respective end of that trial 
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Figure F- 10: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 5. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 11: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D6 in Subject 6. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6. The time displayed in the graph is 
the respective end of that trial 
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Figure F- 12: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D6 in Subject 6. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6. The time displayed in the graph 
is the respective end of that trial 
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Figure F- 13: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 7. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed in 




























































































































































































































































































































































































































































































































































































Figure F- 14: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 7. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 

























































































































































































































































































































































































































































































































Figure F- 15: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 8. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed in 
the graph is the respective end of that trial 
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Figure F- 16: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 8. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 17: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 9. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed in 
the graph is the respective end of that trial 
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Figure F- 18: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 9. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 19: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 10. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 20: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 10. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time 
displayed in the graph is the respective end of that trial 
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Figure F- 21: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 11. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 22: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 11. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time 
displayed in the graph is the respective end of that trial 
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Figure F- 23: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 12. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 24: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 12. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time 
displayed in the graph is the respective end of that trial 
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Figure F- 25: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 13. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 26: The rSO2 levels treatment leg VM and VL during isotonic exercise from D2 to D8 in Subject 13. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time 
displayed in the graph is the respective end of that trial 
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Figure F- 27: The rSO2 levels control leg VM and VL during isotonic exercise from D2 to D8 in Subject 14. (a) D2 (b) D3 (c) D4 (d) D5 (e) D6 (f) D7 (g) D8. The time displayed 
in the graph is the respective end of that trial 
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Figure F- 28: The rSO2 levels treatment leg VM and VL during isotonic exercise from D3 to D8 in Subject 14. (a) D3 (b) D4 (c) D5 (d) D6 (e) D7 (f) D8. The time displayed in 
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